# EDGAR Filing Document

**Accession Number:** 0000904333
**File Stem:** 0001752724-23-067778
**Filing Date:** 2023-3
**Character Count:** 141938
**Document Hash:** 92500a4d803747cada4bff8a134fbd49
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-067778.hdr.sgml**: 20230327

**ACCESSION NUMBER**: 0001752724-23-067778

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230327

**DATE AS OF CHANGE**: 20230327

**PERIOD START**: 20231031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SCHWAB CAPITAL TRUST
- **CENTRAL INDEX KEY:** 0000904333
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07704
- **FILM NUMBER:** 23763938

**BUSINESS ADDRESS:**
- **STREET 1:** 211 MAIN STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** 1-415-667-7000

**MAIL ADDRESS:**
- **STREET 1:** 211 MAIN STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

## Series and Classes Contracts Data

### Schwab Health Care Fund (Series ID: S000005519)

| Class ID   | Class Name              | Ticker Symbol   |
|:---|:---|:---|
| C000015021 | Schwab Health Care Fund | SWHFX           |

## Nport-Ex

Schwab Capital Trust <br>Schwab Core Equity Fund

------

**Portfolio Holdings** as of January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following are the portfolio holdings as of the report date. For more information, please refer to the fund's semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 100.4% OF NET ASSETS | **COMMON STOCKS** 100.4% OF NET ASSETS | **COMMON STOCKS** 100.4% OF NET ASSETS |
| **Banks 3.5%** | **Banks 3.5%** | **Banks 3.5%** |
| East West Bancorp, Inc.  | 311867 | &nbsp;&nbsp;&nbsp;&nbsp; 24487797 |
| Truist Financial Corp.  | 419687 | &nbsp;&nbsp;&nbsp;&nbsp; 20728341 |
|  |  | **45216138** |
| **Capital Goods 5.4%** | **Capital Goods 5.4%** | **Capital Goods 5.4%** |
| A.O. Smith Corp.  | 259182 | &nbsp;&nbsp;&nbsp;&nbsp; 17546621 |
| General Dynamics Corp.  | &nbsp;&nbsp; 45415 | &nbsp;&nbsp;&nbsp;&nbsp; 10584420 |
| Parker-Hannifin Corp.  | 100411 | &nbsp;&nbsp;&nbsp;&nbsp; 32733986 |
| Watsco, Inc.  | &nbsp;&nbsp; 25796 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7412997 |
|  |  | **68278024** |
| **Consumer Durables & Apparel 2.5%** | **Consumer Durables & Apparel 2.5%** | **Consumer Durables & Apparel 2.5%** |
| Deckers Outdoor Corp. \* | &nbsp;&nbsp; 18493 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7905388 |
| PulteGroup, Inc.  | 290887 | &nbsp;&nbsp;&nbsp;&nbsp; 16548561 |
| VF Corp.  | 253575 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7845611 |
|  |  | **32299560** |
| **Consumer Services 2.5%** | **Consumer Services 2.5%** | **Consumer Services 2.5%** |
| Starbucks Corp.  | 295544 | **32255672** |
| **Diversified Financials 3.8%** | **Diversified Financials 3.8%** | **Diversified Financials 3.8%** |
| Berkshire Hathaway, Inc., Class B \* | &nbsp;&nbsp; 91198 | &nbsp;&nbsp;&nbsp;&nbsp; 28410001 |
| CME Group, Inc.  | 113889 | &nbsp;&nbsp;&nbsp;&nbsp; 20119631 |
|  |  | **48529632** |
| **Energy 7.1%** | **Energy 7.1%** | **Energy 7.1%** |
| EOG Resources, Inc.  | 357784 | &nbsp;&nbsp;&nbsp;&nbsp; 47316934 |
| Exxon Mobil Corp.  | 377413 | &nbsp;&nbsp;&nbsp;&nbsp; 43783682 |
|  |  | **91100616** |
| **Food & Staples Retailing 2.6%** | **Food & Staples Retailing 2.6%** | **Food & Staples Retailing 2.6%** |
| Costco Wholesale Corp.  | &nbsp;&nbsp; 26388 | &nbsp;&nbsp;&nbsp;&nbsp; 13487962 |
| Walmart, Inc.  | 137500 | &nbsp;&nbsp;&nbsp;&nbsp; 19782125 |
|  |  | **33270087** |
| **Food, Beverage & Tobacco 4.7%** | **Food, Beverage & Tobacco 4.7%** | **Food, Beverage & Tobacco 4.7%** |
| Constellation Brands, Inc., Class A  | &nbsp;&nbsp; 77750 | &nbsp;&nbsp;&nbsp;&nbsp; 18000680 |
| Diageo plc, ADR  | &nbsp;&nbsp; 54716 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9676525 |
| The Coca-Cola Co.  | 518913 | &nbsp;&nbsp;&nbsp;&nbsp; 31819745 |
|  |  | **59496950** |
| **Health Care Equipment & Services 6.7%** | **Health Care Equipment & Services 6.7%** | **Health Care Equipment & Services 6.7%** |
| Abbott Laboratories  | 186054 | &nbsp;&nbsp;&nbsp;&nbsp; 20568269 |
| Boston Scientific Corp. \* | 421563 | &nbsp;&nbsp;&nbsp;&nbsp; 19497289 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| CVS Health Corp.  | 350654 | &nbsp;&nbsp;&nbsp;&nbsp; 30934696 |
| Intuitive Surgical, Inc. \* | &nbsp;&nbsp; 58916 | &nbsp;&nbsp;&nbsp;&nbsp; 14475072 |
|  |  | **85475326** |
| **Household & Personal Products 1.5%** | **Household & Personal Products 1.5%** | **Household & Personal Products 1.5%** |
| L'Oreal S.A., ADR *(a)* | 141090 | &nbsp;&nbsp;&nbsp;&nbsp; 11650507 |
| The Estee Lauder Cos., Inc., Class A  | &nbsp;&nbsp; 28288 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7838039 |
|  |  | **19488546** |
| **Materials 0.6%** | **Materials 0.6%** | **Materials 0.6%** |
| Linde plc  | &nbsp;&nbsp; 23368 | **7733406** |
| **Media & Entertainment 6.7%** | **Media & Entertainment 6.7%** | **Media & Entertainment 6.7%** |
| Alphabet, Inc., Class A \* | 649580 | &nbsp;&nbsp;&nbsp;&nbsp; 64204487 |
| Meta Platforms, Inc., Class A \* | 144501 | &nbsp;&nbsp;&nbsp;&nbsp; 21526314 |
|  |  | **85730801** |
| **Pharmaceuticals, Biotechnology & Life Sciences 10.1%** | **Pharmaceuticals, Biotechnology & Life Sciences 10.1%** | **Pharmaceuticals, Biotechnology & Life Sciences 10.1%** |
| Eli Lilly & Co.  | &nbsp;&nbsp; 30687 | &nbsp;&nbsp;&nbsp;&nbsp; 10560931 |
| Johnson & Johnson  | 177193 | &nbsp;&nbsp;&nbsp;&nbsp; 28956880 |
| Pfizer, Inc.  | 633044 | &nbsp;&nbsp;&nbsp;&nbsp; 27955223 |
| Roche Holding AG, ADR  | 439715 | &nbsp;&nbsp;&nbsp;&nbsp; 17214842 |
| Thermo Fisher Scientific, Inc.  | &nbsp;&nbsp; 32190 | &nbsp;&nbsp;&nbsp;&nbsp; 18358923 |
| Zoetis, Inc.  | 151573 | &nbsp;&nbsp;&nbsp;&nbsp; 25083816 |
|  |  | **128130615** |
| **Real Estate 1.2%** | **Real Estate 1.2%** | **Real Estate 1.2%** |
| American Tower Corp.  | &nbsp;&nbsp; 67674 | **15117695** |
| **Retailing 5.8%** | **Retailing 5.8%** | **Retailing 5.8%** |
| Amazon.com, Inc. \* | 394176 | &nbsp;&nbsp;&nbsp;&nbsp; 40651371 |
| The Home Depot, Inc.  | &nbsp;&nbsp; 36635 | &nbsp;&nbsp;&nbsp;&nbsp; 11875968 |
| The TJX Cos., Inc.  | 261519 | &nbsp;&nbsp;&nbsp;&nbsp; 21407945 |
|  |  | **73935284** |
| **Semiconductors & Semiconductor Equipment 4.0%** | **Semiconductors & Semiconductor Equipment 4.0%** | **Semiconductors & Semiconductor Equipment 4.0%** |
| &nbsp;&nbsp;&nbsp;&nbsp; ASML Holding N.V. NY Registry Shares, <br> ADR <br>| &nbsp;&nbsp; 20750 | &nbsp;&nbsp;&nbsp;&nbsp; 13712430 |
| Broadcom, Inc.  | &nbsp;&nbsp; 62750 | &nbsp;&nbsp;&nbsp;&nbsp; 36709378 |
|  |  | **50421808** |
| **Software & Services 17.3%** | **Software & Services 17.3%** | **Software & Services 17.3%** |
| Accenture plc, Class A  | &nbsp;&nbsp; 37155 | &nbsp;&nbsp;&nbsp;&nbsp; 10368103 |
| Adobe, Inc. \* | &nbsp;&nbsp; 21000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7777140 |
| &nbsp;&nbsp;&nbsp;&nbsp; Fidelity National Information Services, <br> Inc. <br>| 351918 | &nbsp;&nbsp;&nbsp;&nbsp; 26407927 |
| Microsoft Corp.  | 434007 | &nbsp;&nbsp;&nbsp; 107551274 |

---

**1**

------

Schwab Core Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| PayPal Holdings, Inc. \* | 452716 | &nbsp;&nbsp;&nbsp;&nbsp; 36891827 |
| Visa, Inc., Class A  | 134673 | &nbsp;&nbsp;&nbsp;&nbsp; 31003071 |
|  |  | **219999342** |
| **Technology Hardware & Equipment 7.2%** | **Technology Hardware & Equipment 7.2%** | **Technology Hardware & Equipment 7.2%** |
| Apple Inc.  | 640588 | **92430443** |
| **Telecommunication Services 4.1%** | **Telecommunication Services 4.1%** | **Telecommunication Services 4.1%** |
| AT&T, Inc.  | 921690 | &nbsp;&nbsp;&nbsp;&nbsp; 18774825 |
| Verizon Communications, Inc.  | 795451 | &nbsp;&nbsp;&nbsp;&nbsp; 33066898 |
|  |  | **51841723** |
| **Transportation 1.4%** | **Transportation 1.4%** | **Transportation 1.4%** |
| United Parcel Service, Inc., Class B  | &nbsp;&nbsp; 95449 | **17680018** |
| **Utilities 1.7%** | **Utilities 1.7%** | **Utilities 1.7%** |
| Duke Energy Corp.  | 209354 | **21448317** |
| **Total Common Stocks**<br> **(Cost $953,466,023)** | **Total Common Stocks**<br> **(Cost $953,466,023)** | **1279880003** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **SHORT-TERM INVESTMENTS** 0.2% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.2% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.2% OF NET ASSETS |
| **Money Market Funds 0.2%** | **Money Market Funds 0.2%** | **Money Market Funds 0.2%** |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional <br> U.S. Government Money Market <br> Fund, Premier Class 4.18% *(b)(c)*<br>| 2417975 | **2417975** |
| **Total Short-Term Investments**<br> **(Cost $2,417,975)** | **Total Short-Term Investments**<br> **(Cost $2,417,975)** | **2417975** |
| **Total Investments in Securities**<br> **(Cost $955,883,998)** | **Total Investments in Securities**<br> **(Cost $955,883,998)** | **1282297978** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

*(a)* All or a portion of this security is on loan. Securities on loan were valued at $2,369,903. 

*(b)* The rate shown is the annualized 7-day yield.

*(c)* Security purchased with cash collateral received for securities on loan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

ADR — American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of January 31, 2023:

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $1279880003 | $— | $— | $1279880003 |
| Short-Term Investments<sup>1</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2417975 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2417975 |
| **Total** | **$1282297978** | **$—** | **$—** | **$1282297978** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

Fund investments in mutual funds are classified as Level 1, without consideration to the classification level of the underlying securities held by the mutual funds, which could be Level 1, Level 2 or Level 3.

**2** 

------

Schwab Capital Trust <br>Schwab Dividend Equity Fund

------

**Portfolio Holdings** as of January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following are the portfolio holdings as of the report date. For more information, please refer to the fund's semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 99.9% OF NET ASSETS | **COMMON STOCKS** 99.9% OF NET ASSETS | **COMMON STOCKS** 99.9% OF NET ASSETS |
| **Banks 9.7%** | **Banks 9.7%** | **Banks 9.7%** |
| Bank of America Corp.  | 300000 | &nbsp;&nbsp; 10644000 |
| Citizens Financial Group, Inc.  | 165000 | &nbsp;&nbsp;&nbsp;&nbsp; 7147800 |
| Huntington Bancshares, Inc.  | 340000 | &nbsp;&nbsp;&nbsp;&nbsp; 5157800 |
| JPMorgan Chase & Co.  | 125000 | &nbsp;&nbsp; 17495000 |
| Truist Financial Corp.  | 215000 | &nbsp;&nbsp; 10618850 |
|  |  | **51063450** |
| **Capital Goods 7.9%** | **Capital Goods 7.9%** | **Capital Goods 7.9%** |
| General Dynamics Corp.  | &nbsp;&nbsp; 15000 | &nbsp;&nbsp;&nbsp;&nbsp; 3495900 |
| Illinois Tool Works, Inc.  | &nbsp;&nbsp; 18500 | &nbsp;&nbsp;&nbsp;&nbsp; 4366740 |
| Lockheed Martin Corp.  | &nbsp;&nbsp; 37000 | &nbsp;&nbsp; 17140620 |
| Parker-Hannifin Corp.  | &nbsp;&nbsp; 16500 | &nbsp;&nbsp;&nbsp;&nbsp; 5379000 |
| Raytheon Technologies Corp.  | &nbsp;&nbsp; 58000 | &nbsp;&nbsp;&nbsp;&nbsp; 5791300 |
| Watsco, Inc.  | &nbsp;&nbsp; 20000 | &nbsp;&nbsp;&nbsp;&nbsp; 5747400 |
|  |  | **41920960** |
| **Consumer Services 2.0%** | **Consumer Services 2.0%** | **Consumer Services 2.0%** |
| McDonald's Corp.  | &nbsp;&nbsp; 40000 | **10696000** |
| **Diversified Financials 5.2%** | **Diversified Financials 5.2%** | **Diversified Financials 5.2%** |
| BlackRock, Inc.  | &nbsp;&nbsp; 16500 | &nbsp;&nbsp; 12526965 |
| Morgan Stanley  | 155000 | &nbsp;&nbsp; 15086150 |
|  |  | **27613115** |
| **Energy 8.6%** | **Energy 8.6%** | **Energy 8.6%** |
| Chevron Corp.  | 105000 | &nbsp;&nbsp; 18272100 |
| Exxon Mobil Corp.  | 190000 | &nbsp;&nbsp; 22041900 |
| Kinder Morgan, Inc.  | 290000 | &nbsp;&nbsp;&nbsp;&nbsp; 5307000 |
|  |  | **45621000** |
| **Food & Staples Retailing 2.0%** | **Food & Staples Retailing 2.0%** | **Food & Staples Retailing 2.0%** |
| Walmart, Inc.  | &nbsp;&nbsp; 75000 | **10790250** |
| **Food, Beverage & Tobacco 7.9%** | **Food, Beverage & Tobacco 7.9%** | **Food, Beverage & Tobacco 7.9%** |
| Altria Group, Inc.  | 120000 | &nbsp;&nbsp;&nbsp;&nbsp; 5404800 |
| Philip Morris International, Inc.  | 150000 | &nbsp;&nbsp; 15636000 |
| The Coca-Cola Co.  | 335000 | &nbsp;&nbsp; 20542200 |
|  |  | **41583000** |
| **Health Care Equipment & Services 7.5%** | **Health Care Equipment & Services 7.5%** | **Health Care Equipment & Services 7.5%** |
| Abbott Laboratories  | &nbsp;&nbsp; 77000 | &nbsp;&nbsp;&nbsp;&nbsp; 8512350 |
| CVS Health Corp.  | 110000 | &nbsp;&nbsp;&nbsp;&nbsp; 9704200 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Medtronic plc  | 113000 | &nbsp;&nbsp;&nbsp;&nbsp; 9456970 |
| UnitedHealth Group, Inc.  | &nbsp;&nbsp; 24000 | &nbsp;&nbsp; 11980560 |
|  |  | **39654080** |
| **Household & Personal Products 2.8%** | **Household & Personal Products 2.8%** | **Household & Personal Products 2.8%** |
| The Procter & Gamble Co.  | 105000 | **14949900** |
| **Insurance 1.7%** | **Insurance 1.7%** | **Insurance 1.7%** |
| The Allstate Corp.  | &nbsp;&nbsp; 70000 | **8992900** |
| **Materials 0.9%** | **Materials 0.9%** | **Materials 0.9%** |
| PPG Industries, Inc.  | &nbsp;&nbsp; 37000 | **4822580** |
| **Media & Entertainment 3.4%** | **Media & Entertainment 3.4%** | **Media & Entertainment 3.4%** |
| Activision Blizzard, Inc.  | &nbsp;&nbsp; 30000 | &nbsp;&nbsp;&nbsp;&nbsp; 2297100 |
| Alphabet, Inc., Class A \* | &nbsp;&nbsp; 25000 | &nbsp;&nbsp;&nbsp;&nbsp; 2471000 |
| Comcast Corp., Class A  | 275000 | &nbsp;&nbsp; 10821250 |
| Omnicom Group, Inc.  | &nbsp;&nbsp; 30000 | &nbsp;&nbsp;&nbsp;&nbsp; 2579700 |
|  |  | **18169050** |
| **Pharmaceuticals, Biotechnology & Life Sciences 10.3%** | **Pharmaceuticals, Biotechnology & Life Sciences 10.3%** | **Pharmaceuticals, Biotechnology & Life Sciences 10.3%** |
| Amgen, Inc.  | &nbsp;&nbsp; 30000 | &nbsp;&nbsp;&nbsp;&nbsp; 7572000 |
| Johnson & Johnson  | 103000 | &nbsp;&nbsp; 16832260 |
| Pfizer, Inc.  | 295000 | &nbsp;&nbsp; 13027200 |
| Roche Holding AG  | &nbsp;&nbsp; 40663 | &nbsp;&nbsp; 12693784 |
| Zoetis, Inc.  | &nbsp;&nbsp; 25000 | &nbsp;&nbsp;&nbsp;&nbsp; 4137250 |
|  |  | **54262494** |
| **Real Estate 2.2%** | **Real Estate 2.2%** | **Real Estate 2.2%** |
| Crown Castle, Inc.  | &nbsp;&nbsp; 48750 | &nbsp;&nbsp;&nbsp;&nbsp; 7220362 |
| Lamar Advertising Co., Class A  | &nbsp;&nbsp; 40000 | &nbsp;&nbsp;&nbsp;&nbsp; 4261600 |
|  |  | **11481962** |
| **Retailing 5.4%** | **Retailing 5.4%** | **Retailing 5.4%** |
| Genuine Parts Co.  | &nbsp;&nbsp; 35000 | &nbsp;&nbsp;&nbsp;&nbsp; 5873700 |
| The Home Depot, Inc.  | &nbsp;&nbsp; 35000 | &nbsp;&nbsp; 11345950 |
| The TJX Cos., Inc.  | 135000 | &nbsp;&nbsp; 11051100 |
|  |  | **28270750** |
| **Semiconductors & Semiconductor Equipment 3.1%** | **Semiconductors & Semiconductor Equipment 3.1%** | **Semiconductors & Semiconductor Equipment 3.1%** |
| Broadcom, Inc.  | &nbsp;&nbsp; 27500 | **16087775** |
| **Software & Services 8.0%** | **Software & Services 8.0%** | **Software & Services 8.0%** |
| Accenture plc, Class A  | &nbsp;&nbsp; 36500 | &nbsp;&nbsp; 10185325 |
| International Business Machines Corp.  | &nbsp;&nbsp; 85000 | &nbsp;&nbsp; 11452050 |

---

**3**

------

Schwab Dividend Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Microsoft Corp.  | &nbsp;&nbsp; 45000 | &nbsp;&nbsp; 11151450 |
| Visa, Inc., Class A  | &nbsp;&nbsp; 40000 | &nbsp;&nbsp;&nbsp;&nbsp; 9208400 |
|  |  | **41997225** |
| **Technology Hardware & Equipment 3.6%** | **Technology Hardware & Equipment 3.6%** | **Technology Hardware & Equipment 3.6%** |
| Apple Inc.  | &nbsp;&nbsp; 31500 | &nbsp;&nbsp;&nbsp;&nbsp; 4545135 |
| Cisco Systems, Inc.  | 300000 | &nbsp;&nbsp; 14601000 |
|  |  | **19146135** |
| **Telecommunication Services 2.9%** | **Telecommunication Services 2.9%** | **Telecommunication Services 2.9%** |
| BCE, Inc.  | 100000 | &nbsp;&nbsp;&nbsp;&nbsp; 4730000 |
| Verizon Communications, Inc.  | 260000 | &nbsp;&nbsp; 10808200 |
|  |  | **15538200** |
| **Transportation 2.0%** | **Transportation 2.0%** | **Transportation 2.0%** |
| United Parcel Service, Inc., Class B  | &nbsp;&nbsp; 58000 | **10743340** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Utilities 2.8%** | **Utilities 2.8%** | **Utilities 2.8%** |
| Duke Energy Corp.  | 110000 | &nbsp;&nbsp; 11269500 |
| Eversource Energy  | &nbsp;&nbsp; 40000 | &nbsp;&nbsp;&nbsp;&nbsp; 3293200 |
|  |  | **14562700** |
| **Total Common Stocks**<br> **(Cost $445,188,367)** | **Total Common Stocks**<br> **(Cost $445,188,367)** | **527966866** |
| **Total Investments in Securities**<br> **(Cost $445,188,367)** | **Total Investments in Securities**<br> **(Cost $445,188,367)** | **527966866** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of January 31, 2023:

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $473704372 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $— | $— | $473704372 |
| &nbsp;&nbsp;&nbsp;&nbsp; Pharmaceuticals, Biotechnology & Life Sciences | &nbsp;&nbsp;&nbsp;&nbsp; 41568710 | &nbsp;&nbsp; 12693784 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 54262494 |
| **Total** | **$515273082** | **$12693784** | **$—** | **$527966866** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**4** 

------

Schwab Capital Trust <br>Schwab Large-Cap Growth Fund

------

**Portfolio Holdings** as of January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following are the portfolio holdings as of the report date. For more information, please refer to the fund's semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 96.7% OF NET ASSETS | **COMMON STOCKS** 96.7% OF NET ASSETS | **COMMON STOCKS** 96.7% OF NET ASSETS |
| **Automobiles & Components 1.3%** | **Automobiles & Components 1.3%** | **Automobiles & Components 1.3%** |
| Tesla, Inc. \* | &nbsp;&nbsp; 17116 | **2964834** |
| **Banks 0.7%** | **Banks 0.7%** | **Banks 0.7%** |
| Citizens Financial Group, Inc.  | &nbsp;&nbsp; 38348 | **1661235** |
| **Capital Goods 5.3%** | **Capital Goods 5.3%** | **Capital Goods 5.3%** |
| AGCO Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 9743 | &nbsp;&nbsp;&nbsp;&nbsp; 1345801 |
| Illinois Tool Works, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 4799 | &nbsp;&nbsp;&nbsp;&nbsp; 1132756 |
| Lockheed Martin Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 7652 | &nbsp;&nbsp;&nbsp;&nbsp; 3544866 |
| Parker-Hannifin Corp.  | &nbsp;&nbsp; 10673 | &nbsp;&nbsp;&nbsp;&nbsp; 3479398 |
| Quanta Services, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9885 | &nbsp;&nbsp;&nbsp;&nbsp; 1504398 |
| Watsco, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 3371 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 968724 |
|  |  | **11975943** |
| **Commercial & Professional Services 0.5%** | **Commercial & Professional Services 0.5%** | **Commercial & Professional Services 0.5%** |
| Republic Services, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 8891 | **1109775** |
| **Consumer Durables & Apparel 3.3%** | **Consumer Durables & Apparel 3.3%** | **Consumer Durables & Apparel 3.3%** |
| Deckers Outdoor Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 5897 | &nbsp;&nbsp;&nbsp;&nbsp; 2520849 |
| Lululemon Athletica, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 4211 | &nbsp;&nbsp;&nbsp;&nbsp; 1292272 |
| NIKE, Inc., Class B  | &nbsp;&nbsp; 28300 | &nbsp;&nbsp;&nbsp;&nbsp; 3603439 |
|  |  | **7416560** |
| **Consumer Services 2.1%** | **Consumer Services 2.1%** | **Consumer Services 2.1%** |
| Starbucks Corp.  | &nbsp;&nbsp; 42905 | **4682652** |
| **Diversified Financials 1.6%** | **Diversified Financials 1.6%** | **Diversified Financials 1.6%** |
| CME Group, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 8130 | &nbsp;&nbsp;&nbsp;&nbsp; 1436246 |
| Moody's Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 1857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 599347 |
| MSCI, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 2815 | &nbsp;&nbsp;&nbsp;&nbsp; 1496341 |
|  |  | **3531934** |
| **Energy 1.8%** | **Energy 1.8%** | **Energy 1.8%** |
| EOG Resources, Inc.  | &nbsp;&nbsp; 31449 | **4159130** |
| **Food & Staples Retailing 1.6%** | **Food & Staples Retailing 1.6%** | **Food & Staples Retailing 1.6%** |
| Costco Wholesale Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 7253 | **3707298** |
| **Food, Beverage & Tobacco 3.2%** | **Food, Beverage & Tobacco 3.2%** | **Food, Beverage & Tobacco 3.2%** |
| Constellation Brands, Inc., Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 7145 | &nbsp;&nbsp;&nbsp;&nbsp; 1654210 |
| Diageo plc, ADR  | &nbsp;&nbsp;&nbsp;&nbsp; 8976 | &nbsp;&nbsp;&nbsp;&nbsp; 1587406 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| PepsiCo, Inc.  | &nbsp;&nbsp; 14805 | &nbsp;&nbsp;&nbsp;&nbsp; 2531951 |
| Philip Morris International, Inc.  | &nbsp;&nbsp; 14946 | &nbsp;&nbsp;&nbsp;&nbsp; 1557971 |
|  |  | **7331538** |
| **Health Care Equipment & Services 6.5%** | **Health Care Equipment & Services 6.5%** | **Health Care Equipment & Services 6.5%** |
| Abbott Laboratories  | &nbsp;&nbsp; 14507 | &nbsp;&nbsp;&nbsp;&nbsp; 1603749 |
| Edwards Lifesciences Corp. \* | &nbsp;&nbsp; 19412 | &nbsp;&nbsp;&nbsp;&nbsp; 1488900 |
| IDEXX Laboratories, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 3556 | &nbsp;&nbsp;&nbsp;&nbsp; 1708658 |
| Intuitive Surgical, Inc. \* | &nbsp;&nbsp; 16517 | &nbsp;&nbsp;&nbsp;&nbsp; 4058062 |
| UnitedHealth Group, Inc.  | &nbsp;&nbsp; 11673 | &nbsp;&nbsp;&nbsp;&nbsp; 5827045 |
|  |  | **14686414** |
| **Household & Personal Products 2.0%** | **Household & Personal Products 2.0%** | **Household & Personal Products 2.0%** |
| The Estee Lauder Cos., Inc., Class A  | &nbsp;&nbsp; 16531 | **4580409** |
| **Materials 0.6%** | **Materials 0.6%** | **Materials 0.6%** |
| The Sherwin-Williams Co.  | &nbsp;&nbsp;&nbsp;&nbsp; 5335 | **1262208** |
| **Media & Entertainment 5.2%** | **Media & Entertainment 5.2%** | **Media & Entertainment 5.2%** |
| Alphabet, Inc., Class A \* | 120240 | **11884522** |
| **Pharmaceuticals, Biotechnology & Life Sciences 6.0%** | **Pharmaceuticals, Biotechnology & Life Sciences 6.0%** | **Pharmaceuticals, Biotechnology & Life Sciences 6.0%** |
| Eli Lilly & Co.  | &nbsp;&nbsp; 10599 | &nbsp;&nbsp;&nbsp;&nbsp; 3647646 |
| Horizon Therapeutics plc \* | &nbsp;&nbsp; 11420 | &nbsp;&nbsp;&nbsp;&nbsp; 1253002 |
| Pfizer, Inc.  | &nbsp;&nbsp; 43226 | &nbsp;&nbsp;&nbsp;&nbsp; 1908860 |
| Thermo Fisher Scientific, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 6166 | &nbsp;&nbsp;&nbsp;&nbsp; 3516655 |
| Zoetis, Inc.  | &nbsp;&nbsp; 20079 | &nbsp;&nbsp;&nbsp;&nbsp; 3322874 |
|  |  | **13649037** |
| **Real Estate 0.6%** | **Real Estate 0.6%** | **Real Estate 0.6%** |
| American Tower Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 6424 | **1435057** |
| **Retailing 8.5%** | **Retailing 8.5%** | **Retailing 8.5%** |
| Amazon.com, Inc. \* | 114359 | &nbsp;&nbsp; 11793844 |
| O'Reilly Automotive, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 1888 | &nbsp;&nbsp;&nbsp;&nbsp; 1495957 |
| The Home Depot, Inc.  | &nbsp;&nbsp; 12073 | &nbsp;&nbsp;&nbsp;&nbsp; 3913704 |
| The TJX Cos., Inc.  | &nbsp;&nbsp; 25285 | &nbsp;&nbsp;&nbsp;&nbsp; 2069830 |
|  |  | **19273335** |
| **Semiconductors & Semiconductor Equipment 7.2%** | **Semiconductors & Semiconductor Equipment 7.2%** | **Semiconductors & Semiconductor Equipment 7.2%** |
| Advanced Micro Devices, Inc. \* | &nbsp;&nbsp; 21181 | &nbsp;&nbsp;&nbsp;&nbsp; 1591752 |
| &nbsp;&nbsp;&nbsp;&nbsp; ASML Holding N.V. NY Registry Shares, <br> ADR <br>| &nbsp;&nbsp;&nbsp;&nbsp; 5852 | &nbsp;&nbsp;&nbsp;&nbsp; 3867236 |
| Broadcom, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9252 | &nbsp;&nbsp;&nbsp;&nbsp; 5412512 |
| NVIDIA Corp.  | &nbsp;&nbsp; 27403 | &nbsp;&nbsp;&nbsp;&nbsp; 5353724 |
|  |  | **16225224** |

---

**5**

------

Schwab Large-Cap Growth Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Software & Services 25.6%** | **Software & Services 25.6%** | **Software & Services 25.6%** |
| Accenture plc, Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 8194 | &nbsp;&nbsp;&nbsp;&nbsp; 2286536 |
| Adobe, Inc. \* | &nbsp;&nbsp; 10158 | &nbsp;&nbsp;&nbsp;&nbsp; 3761914 |
| Fortinet, Inc. \* | &nbsp;&nbsp; 27385 | &nbsp;&nbsp;&nbsp;&nbsp; 1433331 |
| Gartner, Inc. \* | &nbsp;&nbsp; 10548 | &nbsp;&nbsp;&nbsp;&nbsp; 3566701 |
| Intuit, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 4573 | &nbsp;&nbsp;&nbsp;&nbsp; 1932870 |
| Mastercard, Inc., Class A  | &nbsp;&nbsp; 11969 | &nbsp;&nbsp;&nbsp;&nbsp; 4435711 |
| Microsoft Corp.  | &nbsp;&nbsp; 99364 | &nbsp;&nbsp; 24623393 |
| Palo Alto Networks, Inc. \* | &nbsp;&nbsp; 11676 | &nbsp;&nbsp;&nbsp;&nbsp; 1852280 |
| Paychex, Inc.  | &nbsp;&nbsp; 13902 | &nbsp;&nbsp;&nbsp;&nbsp; 1610686 |
| PayPal Holdings, Inc. \* | &nbsp;&nbsp; 39156 | &nbsp;&nbsp;&nbsp;&nbsp; 3190822 |
| ServiceNow, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 2645 | &nbsp;&nbsp;&nbsp;&nbsp; 1203819 |
| Synopsys, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 5560 | &nbsp;&nbsp;&nbsp;&nbsp; 1966850 |
| Visa, Inc., Class A  | &nbsp;&nbsp; 27048 | &nbsp;&nbsp;&nbsp;&nbsp; 6226720 |
|  |  | **58091633** |
| **Technology Hardware & Equipment 11.9%** | **Technology Hardware & Equipment 11.9%** | **Technology Hardware & Equipment 11.9%** |
| Apple Inc.  | 186176 | **26863335** |
| **Transportation 1.2%** | **Transportation 1.2%** | **Transportation 1.2%** |
| United Parcel Service, Inc., Class B  | &nbsp;&nbsp; 14196 | **2629525** |
| **Total Common Stocks**<br> **(Cost $127,583,436)** | **Total Common Stocks**<br> **(Cost $127,583,436)** | **219121598** |
| **Total Investments in Securities**<br> **(Cost $127,583,436)** | **Total Investments in Securities**<br> **(Cost $127,583,436)** | **219121598** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | NUMBER OF<br> CONTRACTS<br>| NOTIONAL<br> AMOUNT<br> ($)<br>| CURRENT VALUE/<br> UNREALIZED<br> APPRECIATION<br> ($)<br>|
| **FUTURES CONTRACTS** | **FUTURES CONTRACTS** | **FUTURES CONTRACTS** | **FUTURES CONTRACTS** |
| **Long** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; S&P 500 Index, e-mini, expires <br> 03/17/23<br>| 6 | 1227000 | **27605** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

ADR — American Depositary Receipt

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of January 31, 2023:

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $219121598 | $— | $— | $219121598 |
| Futures Contracts<sup>2</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27605 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27605 |
| **Total** | **$219149203** | **$—** | **$—** | **$219149203** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings. <br> <sup>2</sup> Futures contracts are reported at cumulative unrealized appreciation or depreciation.

**6** 

------

Schwab Capital Trust <br>Schwab Small-Cap Equity Fund

------

**Portfolio Holdings** as of January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following are the portfolio holdings as of the report date. For more information, please refer to the fund's semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 99.9% OF NET ASSETS | **COMMON STOCKS** 99.9% OF NET ASSETS | **COMMON STOCKS** 99.9% OF NET ASSETS |
| **Automobiles & Components 2.6%** | **Automobiles & Components 2.6%** | **Automobiles & Components 2.6%** |
| &nbsp;&nbsp;&nbsp;&nbsp; American Axle & Manufacturing Holdings, <br> Inc. \*<br>| 276405 | &nbsp;&nbsp;&nbsp;&nbsp; 2451712 |
| LCI Industries  | &nbsp;&nbsp; 18783 | &nbsp;&nbsp;&nbsp;&nbsp; 2107828 |
| Modine Manufacturing Co. \* | 123507 | &nbsp;&nbsp;&nbsp;&nbsp; 2950582 |
| Patrick Industries, Inc.  | &nbsp;&nbsp; 39066 | &nbsp;&nbsp;&nbsp;&nbsp; 2772514 |
| The Goodyear Tire & Rubber Co. \* | &nbsp;&nbsp; 63926 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 719168 |
| Visteon Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 3706 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 579396 |
| Winnebago Industries, Inc.  | &nbsp;&nbsp; 38620 | &nbsp;&nbsp;&nbsp;&nbsp; 2459322 |
|  |  | **14040522** |
| **Banks 10.2%** | **Banks 10.2%** | **Banks 10.2%** |
| Associated Banc-Corp.  | 258793 | &nbsp;&nbsp;&nbsp;&nbsp; 5799551 |
| Axos Financial, Inc. \* | &nbsp;&nbsp; 12857 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 618679 |
| Banner Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 7886 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 511249 |
| Cathay General Bancorp  | &nbsp;&nbsp; 98524 | &nbsp;&nbsp;&nbsp;&nbsp; 4331115 |
| Community Trust Bancorp, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 5199 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 223973 |
| Customers Bancorp, Inc. \* | &nbsp;&nbsp; 18970 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 576119 |
| Eagle Bancorp, Inc.  | &nbsp;&nbsp; 35468 | &nbsp;&nbsp;&nbsp;&nbsp; 1684375 |
| Enterprise Financial Services Corp.  | &nbsp;&nbsp; 37332 | &nbsp;&nbsp;&nbsp;&nbsp; 1990542 |
| Essent Group Ltd.  | &nbsp;&nbsp; 27018 | &nbsp;&nbsp;&nbsp;&nbsp; 1189603 |
| First BanCorp  | 180265 | &nbsp;&nbsp;&nbsp;&nbsp; 2424564 |
| Great Southern Bancorp, Inc.  | &nbsp;&nbsp; 57069 | &nbsp;&nbsp;&nbsp;&nbsp; 3335112 |
| Hancock Whitney Corp.  | 102837 | &nbsp;&nbsp;&nbsp;&nbsp; 5294049 |
| Hanmi Financial Corp.  | &nbsp;&nbsp; 55564 | &nbsp;&nbsp;&nbsp;&nbsp; 1294086 |
| Hope Bancorp, Inc.  | 127362 | &nbsp;&nbsp;&nbsp;&nbsp; 1641696 |
| International Bancshares Corp.  | 100339 | &nbsp;&nbsp;&nbsp;&nbsp; 4702889 |
| Metropolitan Bank Holding Corp. \* | &nbsp;&nbsp; 23146 | &nbsp;&nbsp;&nbsp;&nbsp; 1374409 |
| MGIC Investment Corp.  | &nbsp;&nbsp; 95345 | &nbsp;&nbsp;&nbsp;&nbsp; 1346271 |
| Northfield Bancorp, Inc.  | 217924 | &nbsp;&nbsp;&nbsp;&nbsp; 3257964 |
| OceanFirst Financial Corp.  | &nbsp;&nbsp; 51090 | &nbsp;&nbsp;&nbsp;&nbsp; 1222073 |
| Radian Group, Inc.  | &nbsp;&nbsp; 87198 | &nbsp;&nbsp;&nbsp;&nbsp; 1927076 |
| Renasant Corp.  | &nbsp;&nbsp; 66293 | &nbsp;&nbsp;&nbsp;&nbsp; 2358705 |
| Republic Bancorp, Inc., Class A  | &nbsp;&nbsp; 30525 | &nbsp;&nbsp;&nbsp;&nbsp; 1373015 |
| UMB Financial Corp.  | &nbsp;&nbsp; 34705 | &nbsp;&nbsp;&nbsp;&nbsp; 3130044 |
| Washington Federal, Inc.  | 106704 | &nbsp;&nbsp;&nbsp;&nbsp; 3783724 |
| Western New England Bancorp, Inc.  | &nbsp;&nbsp; 44667 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 435503 |
|  |  | **55826386** |
| **Capital Goods 11.5%** | **Capital Goods 11.5%** | **Capital Goods 11.5%** |
| AAR Corp. \* | &nbsp;&nbsp; 53345 | &nbsp;&nbsp;&nbsp;&nbsp; 2744067 |
| Alamo Group, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 2096 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 327961 |
| Applied Industrial Technologies, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 6332 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 906806 |
| Atkore, Inc. \* | &nbsp;&nbsp; 64610 | &nbsp;&nbsp;&nbsp;&nbsp; 8415452 |
| AZZ, Inc.  | &nbsp;&nbsp; 38600 | &nbsp;&nbsp;&nbsp;&nbsp; 1639728 |
| Boise Cascade Co.  | &nbsp;&nbsp; 21256 | &nbsp;&nbsp;&nbsp;&nbsp; 1593562 |
| Ducommun, Inc. \* | &nbsp;&nbsp; 24724 | &nbsp;&nbsp;&nbsp;&nbsp; 1428553 |
| EMCOR Group, Inc.  | &nbsp;&nbsp; 34512 | &nbsp;&nbsp;&nbsp;&nbsp; 5116404 |
| Encore Wire Corp.  | &nbsp;&nbsp; 23614 | &nbsp;&nbsp;&nbsp;&nbsp; 3812008 |
| GrafTech International Ltd.  | 241374 | &nbsp;&nbsp;&nbsp;&nbsp; 1578586 |
| Griffon Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 9521 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 389218 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Helios Technologies, Inc.  | &nbsp;&nbsp; 19804 | &nbsp;&nbsp;&nbsp;&nbsp; 1307064 |
| Herc Holdings, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9243 | &nbsp;&nbsp;&nbsp;&nbsp; 1435623 |
| Hillenbrand, Inc.  | &nbsp;&nbsp; 24439 | &nbsp;&nbsp;&nbsp;&nbsp; 1145212 |
| IES Holdings, Inc. \* | &nbsp;&nbsp; 16376 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 651929 |
| Maxar Technologies, Inc.  | &nbsp;&nbsp; 17709 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 915024 |
| Moog, Inc., Class A  | &nbsp;&nbsp; 63318 | &nbsp;&nbsp;&nbsp;&nbsp; 6035472 |
| Mueller Industries, Inc.  | &nbsp;&nbsp; 79111 | &nbsp;&nbsp;&nbsp;&nbsp; 5185726 |
| MYR Group, Inc. \* | &nbsp;&nbsp; 11863 | &nbsp;&nbsp;&nbsp;&nbsp; 1175149 |
| Preformed Line Products Co.  | &nbsp;&nbsp;&nbsp;&nbsp; 9869 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 871729 |
| Proto Labs, Inc. \* | &nbsp;&nbsp; 13625 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 416925 |
| Shoals Technologies Group, Inc., Class A \* | &nbsp;&nbsp; 29734 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 829281 |
| Standex International Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 2939 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 339660 |
| Sterling Infrastructure, Inc. \* | &nbsp;&nbsp; 93342 | &nbsp;&nbsp;&nbsp;&nbsp; 3396715 |
| Terex Corp.  | &nbsp;&nbsp; 40650 | &nbsp;&nbsp;&nbsp;&nbsp; 2071930 |
| Titan International, Inc. \* | &nbsp;&nbsp; 86118 | &nbsp;&nbsp;&nbsp;&nbsp; 1437309 |
| Titan Machinery, Inc. \* | &nbsp;&nbsp; 20665 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 908020 |
| UFP Industries, Inc.  | &nbsp;&nbsp; 24713 | &nbsp;&nbsp;&nbsp;&nbsp; 2311901 |
| V2X, Inc. \* | &nbsp;&nbsp; 64236 | &nbsp;&nbsp;&nbsp;&nbsp; 2836662 |
| Wabash National Corp.  | &nbsp;&nbsp; 42901 | &nbsp;&nbsp;&nbsp;&nbsp; 1105130 |
| Watts Water Technologies, Inc., Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 3480 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 569050 |
| Zurn Elkay Water Solutions Corp.  | &nbsp;&nbsp; 15042 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 328818 |
|  |  | **63226674** |
| **Commercial & Professional Services 2.3%** | **Commercial & Professional Services 2.3%** | **Commercial & Professional Services 2.3%** |
| ACCO Brands Corp.  | &nbsp;&nbsp; 41872 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 265887 |
| Casella Waste Systems, Inc., Class A \* | &nbsp;&nbsp; 21365 | &nbsp;&nbsp;&nbsp;&nbsp; 1711764 |
| Heidrick & Struggles International, Inc.  | &nbsp;&nbsp; 15962 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 490991 |
| Insperity, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 2354 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260235 |
| Kforce, Inc.  | &nbsp;&nbsp; 38447 | &nbsp;&nbsp;&nbsp;&nbsp; 2158030 |
| Korn Ferry  | &nbsp;&nbsp; 10108 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 545731 |
| Mastech Digital, Inc. \* | &nbsp;&nbsp; 20611 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 276099 |
| NV5 Global, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 9232 | &nbsp;&nbsp;&nbsp;&nbsp; 1230533 |
| SP Plus Corp. \* | &nbsp;&nbsp; 82548 | &nbsp;&nbsp;&nbsp;&nbsp; 3112885 |
| Tetra Tech, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9540 | &nbsp;&nbsp;&nbsp;&nbsp; 1483661 |
| The GEO Group, Inc. \* | &nbsp;&nbsp; 30437 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 350025 |
| TriNet Group, Inc. \* | &nbsp;&nbsp; 11902 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 898006 |
|  |  | **12783847** |
| **Consumer Durables & Apparel 1.1%** | **Consumer Durables & Apparel 1.1%** | **Consumer Durables & Apparel 1.1%** |
| Crocs, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 8680 | &nbsp;&nbsp;&nbsp;&nbsp; 1056964 |
| La-Z-Boy, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 3982 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 113208 |
| Malibu Boats, Inc., Class A \* | &nbsp;&nbsp;&nbsp;&nbsp; 7258 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 439762 |
| MasterCraft Boat Holdings, Inc. \* | &nbsp;&nbsp; 44820 | &nbsp;&nbsp;&nbsp;&nbsp; 1289023 |
| Oxford Industries, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9747 | &nbsp;&nbsp;&nbsp;&nbsp; 1142543 |
| Skyline Champion Corp. \* | &nbsp;&nbsp; 17212 | &nbsp;&nbsp;&nbsp;&nbsp; 1014648 |
| Vista Outdoor, Inc. \* | &nbsp;&nbsp; 36811 | &nbsp;&nbsp;&nbsp;&nbsp; 1080403 |
|  |  | **6136551** |
| **Consumer Services 4.6%** | **Consumer Services 4.6%** | **Consumer Services 4.6%** |
| Bloomin' Brands, Inc.  | 119304 | &nbsp;&nbsp;&nbsp;&nbsp; 2893122 |
| Bluegreen Vacations Holding Corp.  | &nbsp;&nbsp; 11100 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 360084 |
| Boyd Gaming Corp.  | &nbsp;&nbsp; 34708 | &nbsp;&nbsp;&nbsp;&nbsp; 2162656 |
| Dave & Buster's Entertainment, Inc. \* | &nbsp;&nbsp; 54281 | &nbsp;&nbsp;&nbsp;&nbsp; 2353081 |

---

**7**

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Everi Holdings, Inc. \* | &nbsp;&nbsp; 91398 | &nbsp;&nbsp;&nbsp;&nbsp; 1587583 |
| Golden Entertainment, Inc. \* | &nbsp;&nbsp; 33363 | &nbsp;&nbsp;&nbsp;&nbsp; 1317839 |
| Hilton Grand Vacations, Inc. \* | &nbsp;&nbsp; 69546 | &nbsp;&nbsp;&nbsp;&nbsp; 3293699 |
| International Game Technology plc  | &nbsp;&nbsp; 19494 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 515616 |
| Light & Wonder, Inc., Class A \* | &nbsp;&nbsp; 22522 | &nbsp;&nbsp;&nbsp;&nbsp; 1469561 |
| PlayAGS, Inc. \* | 102958 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 680553 |
| Red Rock Resorts, Inc., Class A  | &nbsp;&nbsp; 15232 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 685592 |
| SeaWorld Entertainment, Inc. \* | &nbsp;&nbsp; 40447 | &nbsp;&nbsp;&nbsp;&nbsp; 2523488 |
| Stride, Inc. \* | &nbsp;&nbsp; 77210 | &nbsp;&nbsp;&nbsp;&nbsp; 3314625 |
| Texas Roadhouse, Inc.  | &nbsp;&nbsp; 23691 | &nbsp;&nbsp;&nbsp;&nbsp; 2379287 |
|  |  | **25536786** |
| **Diversified Financials 3.2%** | **Diversified Financials 3.2%** | **Diversified Financials 3.2%** |
| Donnelley Financial Solutions, Inc. \* | &nbsp;&nbsp; 28342 | &nbsp;&nbsp;&nbsp;&nbsp; 1292679 |
| Enova International, Inc. \* | &nbsp;&nbsp; 76808 | &nbsp;&nbsp;&nbsp;&nbsp; 3506285 |
| OneMain Holdings, Inc.  | &nbsp;&nbsp; 80201 | &nbsp;&nbsp;&nbsp;&nbsp; 3459871 |
| Oportun Financial Corp. \* | &nbsp;&nbsp; 64300 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 450743 |
| Piper Sandler Cos.  | &nbsp;&nbsp;&nbsp;&nbsp; 4440 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 630924 |
| Regional Management Corp.  | &nbsp;&nbsp; 56991 | &nbsp;&nbsp;&nbsp;&nbsp; 1965619 |
| StepStone Group, Inc., Class A  | &nbsp;&nbsp; 38659 | &nbsp;&nbsp;&nbsp;&nbsp; 1128456 |
| Stifel Financial Corp.  | &nbsp;&nbsp; 42385 | &nbsp;&nbsp;&nbsp;&nbsp; 2857173 |
| Virtus Investment Partners, Inc.  | &nbsp;&nbsp; 11410 | &nbsp;&nbsp;&nbsp;&nbsp; 2451781 |
|  |  | **17743531** |
| **Energy 6.2%** | **Energy 6.2%** | **Energy 6.2%** |
| Arch Resources, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 5983 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 885604 |
| Callon Petroleum Co. \* | &nbsp;&nbsp; 12587 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 535577 |
| ChampionX Corp.  | &nbsp;&nbsp; 19780 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 653136 |
| CONSOL Energy, Inc.  | &nbsp;&nbsp; 19809 | &nbsp;&nbsp;&nbsp;&nbsp; 1145554 |
| CVR Energy, Inc.  | &nbsp;&nbsp; 77969 | &nbsp;&nbsp;&nbsp;&nbsp; 2588571 |
| Delek US Holdings, Inc.  | &nbsp;&nbsp; 89594 | &nbsp;&nbsp;&nbsp;&nbsp; 2397535 |
| Equitrans Midstream Corp.  | 175127 | &nbsp;&nbsp;&nbsp;&nbsp; 1269671 |
| Liberty Energy, Inc., Class A  | &nbsp;&nbsp; 96622 | &nbsp;&nbsp;&nbsp;&nbsp; 1529526 |
| Magnolia Oil & Gas Corp., Class A  | &nbsp;&nbsp; 78663 | &nbsp;&nbsp;&nbsp;&nbsp; 1857233 |
| Matador Resources Co.  | &nbsp;&nbsp; 39715 | &nbsp;&nbsp;&nbsp;&nbsp; 2627544 |
| NexTier Oilfield Solutions, Inc. \* | &nbsp;&nbsp; 97329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 916839 |
| Oceaneering International, Inc. \* | &nbsp;&nbsp; 79562 | &nbsp;&nbsp;&nbsp;&nbsp; 1698649 |
| Ovintiv, Inc.  | &nbsp;&nbsp; 17896 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 881020 |
| Par Pacific Holdings, Inc. \* | &nbsp;&nbsp; 17646 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 471678 |
| Patterson-UTI Energy, Inc.  | 109152 | &nbsp;&nbsp;&nbsp;&nbsp; 1833754 |
| PBF Energy, Inc., Class A  | &nbsp;&nbsp; 65086 | &nbsp;&nbsp;&nbsp;&nbsp; 2732961 |
| PDC Energy, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9439 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 639303 |
| Peabody Energy Corp. \* | &nbsp;&nbsp; 27391 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 763935 |
| REX American Resources Corp. \* | &nbsp;&nbsp; 47497 | &nbsp;&nbsp;&nbsp;&nbsp; 1554102 |
| SM Energy Co.  | &nbsp;&nbsp; 60353 | &nbsp;&nbsp;&nbsp;&nbsp; 1983803 |
| Southwestern Energy Co. \* | 274016 | &nbsp;&nbsp;&nbsp;&nbsp; 1512568 |
| Teekay Corp. \* | 150033 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 729160 |
| Teekay Tankers Ltd., Class A \* | &nbsp;&nbsp; 14659 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 449885 |
| US Silica Holdings, Inc. \* | 100940 | &nbsp;&nbsp;&nbsp;&nbsp; 1235506 |
| W&T Offshore, Inc. \* | 126667 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 787869 |
| World Fuel Services Corp.  | &nbsp;&nbsp; 13272 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 375598 |
|  |  | **34056581** |
| **Food & Staples Retailing 1.0%** | **Food & Staples Retailing 1.0%** | **Food & Staples Retailing 1.0%** |
| BJ's Wholesale Club Holdings, Inc. \* | &nbsp;&nbsp; 49992 | &nbsp;&nbsp;&nbsp;&nbsp; 3622920 |
| United Natural Foods, Inc. \* | &nbsp;&nbsp; 44261 | &nbsp;&nbsp;&nbsp;&nbsp; 1842143 |
|  |  | **5465063** |
| **Food, Beverage & Tobacco 3.0%** | **Food, Beverage & Tobacco 3.0%** | **Food, Beverage & Tobacco 3.0%** |
| Coca-Cola Consolidated, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 7603 | &nbsp;&nbsp;&nbsp;&nbsp; 3853048 |
| Darling Ingredients, Inc. \* | &nbsp;&nbsp; 32115 | &nbsp;&nbsp;&nbsp;&nbsp; 2128903 |
| National Beverage Corp. \* | &nbsp;&nbsp; 34764 | &nbsp;&nbsp;&nbsp;&nbsp; 1536569 |
| Primo Water Corp.  | 189849 | &nbsp;&nbsp;&nbsp;&nbsp; 2971137 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| The Simply Good Foods Co. \* | &nbsp;&nbsp; 35518 | &nbsp;&nbsp;&nbsp;&nbsp; 1289304 |
| Vector Group Ltd.  | 355243 | &nbsp;&nbsp;&nbsp;&nbsp; 4600397 |
|  |  | **16379358** |
| **Health Care Equipment & Services 6.5%** | **Health Care Equipment & Services 6.5%** | **Health Care Equipment & Services 6.5%** |
| Accuray, Inc. \* | 283668 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 714843 |
| Addus HomeCare Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 1996 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 214610 |
| AirSculpt Technologies, Inc. *(a)* | &nbsp;&nbsp; 44104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 256685 |
| Alignment Healthcare, Inc. \* | &nbsp;&nbsp; 54831 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 677163 |
| AMN Healthcare Services, Inc. \* | &nbsp;&nbsp; 36010 | &nbsp;&nbsp;&nbsp;&nbsp; 3451198 |
| Apollo Medical Holdings, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 1186 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42269 |
| Avanos Medical, Inc. \* | &nbsp;&nbsp; 73552 | &nbsp;&nbsp;&nbsp;&nbsp; 2253633 |
| Cerus Corp. \* | 270093 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 848092 |
| Cross Country Healthcare, Inc. \* | &nbsp;&nbsp; 17202 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 477355 |
| Evolent Health, Inc., Class A \* | &nbsp;&nbsp; 33989 | &nbsp;&nbsp;&nbsp;&nbsp; 1095126 |
| Inspire Medical Systems, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 5549 | &nbsp;&nbsp;&nbsp;&nbsp; 1404230 |
| Lantheus Holdings, Inc. \* | &nbsp;&nbsp; 36689 | &nbsp;&nbsp;&nbsp;&nbsp; 2109617 |
| LeMaitre Vascular, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 9772 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 461043 |
| LivaNova plc \* | &nbsp;&nbsp; 18242 | &nbsp;&nbsp;&nbsp;&nbsp; 1025200 |
| Merit Medical Systems, Inc. \* | &nbsp;&nbsp; 52497 | &nbsp;&nbsp;&nbsp;&nbsp; 3745661 |
| ModivCare, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 4961 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 532117 |
| NeoGenomics, Inc. \* | &nbsp;&nbsp; 26010 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 308999 |
| NextGen Healthcare, Inc. \* | &nbsp;&nbsp; 68253 | &nbsp;&nbsp;&nbsp;&nbsp; 1298172 |
| NuVasive, Inc. \* | &nbsp;&nbsp; 11539 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 526178 |
| OmniAb, Inc., Class A \**(b)* | &nbsp;&nbsp;&nbsp;&nbsp; 5507 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0 |
| OmniAb, Inc., Class B \**(b)* | &nbsp;&nbsp;&nbsp;&nbsp; 5507 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 0 |
| Option Care Health, Inc. \* | &nbsp;&nbsp; 54941 | &nbsp;&nbsp;&nbsp;&nbsp; 1586147 |
| Progyny, Inc. \* | &nbsp;&nbsp; 14584 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 501544 |
| Shockwave Medical, Inc. \* | &nbsp;&nbsp; 12292 | &nbsp;&nbsp;&nbsp;&nbsp; 2310036 |
| STAAR Surgical Co. \* | &nbsp;&nbsp; 21572 | &nbsp;&nbsp;&nbsp;&nbsp; 1521905 |
| Tenet Healthcare Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 7942 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 435619 |
| The Ensign Group, Inc.  | &nbsp;&nbsp; 42417 | &nbsp;&nbsp;&nbsp;&nbsp; 3955385 |
| Utah Medical Products, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 4981 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 458900 |
| Veradigm, Inc. \* | 107604 | &nbsp;&nbsp;&nbsp;&nbsp; 1927188 |
| Zynex, Inc. \* | 116814 | &nbsp;&nbsp;&nbsp;&nbsp; 1650582 |
|  |  | **35789497** |
| **Household & Personal Products 0.4%** | **Household & Personal Products 0.4%** | **Household & Personal Products 0.4%** |
| BellRing Brands, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 3507 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 99458 |
| elf Beauty, Inc. \* | &nbsp;&nbsp; 10984 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 632129 |
| Herbalife Nutrition Ltd. \* | &nbsp;&nbsp; 21933 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 385363 |
| Nature's Sunshine Products, Inc. \* | &nbsp;&nbsp; 94898 | &nbsp;&nbsp;&nbsp;&nbsp; 1002123 |
|  |  | **2119073** |
| **Insurance 2.4%** | **Insurance 2.4%** | **Insurance 2.4%** |
| &nbsp;&nbsp;&nbsp;&nbsp; American Equity Investment Life Holding <br> Co. <br>| &nbsp;&nbsp; 64756 | &nbsp;&nbsp;&nbsp;&nbsp; 3085623 |
| CNO Financial Group, Inc.  | 201889 | &nbsp;&nbsp;&nbsp;&nbsp; 5200661 |
| Investors Title Co.  | &nbsp;&nbsp;&nbsp;&nbsp; 1858 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300996 |
| Kinsale Capital Group, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 2736 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 761812 |
| National Western Life Group, Inc., Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 5294 | &nbsp;&nbsp;&nbsp;&nbsp; 1465379 |
| Stewart Information Services Corp.  | &nbsp;&nbsp; 30811 | &nbsp;&nbsp;&nbsp;&nbsp; 1471842 |
| United Fire Group, Inc.  | &nbsp;&nbsp; 26505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 834642 |
|  |  | **13120955** |
| **Materials 3.2%** | **Materials 3.2%** | **Materials 3.2%** |
| AdvanSix, Inc.  | &nbsp;&nbsp; 17366 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 750906 |
| Alcoa Corp.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 159 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8306 |
| Alpha Metallurgical Resources, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 4159 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 669308 |
| Avient Corp.  | &nbsp;&nbsp; 71456 | &nbsp;&nbsp;&nbsp;&nbsp; 2895397 |
| Cabot Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 7276 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 548101 |
| Commercial Metals Co.  | &nbsp;&nbsp; 15557 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 844278 |
| Constellium SE \* | 125507 | &nbsp;&nbsp;&nbsp;&nbsp; 1823617 |
| Ecovyst, Inc. \* | 192072 | &nbsp;&nbsp;&nbsp;&nbsp; 2014835 |
| Ingevity Corp. \* | &nbsp;&nbsp; 14245 | &nbsp;&nbsp;&nbsp;&nbsp; 1174358 |

---

**8** 

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| LSB Industries, Inc. \* | &nbsp;&nbsp; 39787 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 505693 |
| Rayonier Advanced Materials, Inc. \* | 105791 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 733132 |
| Ryerson Holding Corp.  | &nbsp;&nbsp; 64864 | &nbsp;&nbsp;&nbsp;&nbsp; 2475859 |
| Schnitzer Steel Industries, Inc., Class A  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8798 |
| TimkenSteel Corp. \* | &nbsp;&nbsp; 38185 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 751099 |
| Tronox Holdings plc, Class A  | &nbsp;&nbsp; 84904 | &nbsp;&nbsp;&nbsp;&nbsp; 1456103 |
| Valhi, Inc.  | &nbsp;&nbsp; 26078 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 673595 |
|  |  | **17333385** |
| **Media & Entertainment 2.3%** | **Media & Entertainment 2.3%** | **Media & Entertainment 2.3%** |
| Cargurus, Inc. \* | &nbsp;&nbsp; 30336 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 535430 |
| Cars.com, Inc. \* | 141524 | &nbsp;&nbsp;&nbsp;&nbsp; 2420060 |
| Entravision Communications Corp., Class A  | 227618 | &nbsp;&nbsp;&nbsp;&nbsp; 1479517 |
| Gaia, Inc. \* | &nbsp;&nbsp; 65502 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 239082 |
| Gannett Co., Inc. \* | 148450 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 335497 |
| iHeartMedia, Inc., Class A \* | &nbsp;&nbsp; 97406 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 754896 |
| Outbrain, Inc. \* | &nbsp;&nbsp; 72000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 354240 |
| Shutterstock, Inc.  | &nbsp;&nbsp; 29062 | &nbsp;&nbsp;&nbsp;&nbsp; 2187497 |
| Yelp, Inc. \* | &nbsp;&nbsp; 87001 | &nbsp;&nbsp;&nbsp;&nbsp; 2741402 |
| Ziff Davis, Inc. \* | &nbsp;&nbsp; 20224 | &nbsp;&nbsp;&nbsp;&nbsp; 1809644 |
|  |  | **12857265** |
| **Pharmaceuticals, Biotechnology & Life Sciences 11.0%** | **Pharmaceuticals, Biotechnology & Life Sciences 11.0%** | **Pharmaceuticals, Biotechnology & Life Sciences 11.0%** |
| 2seventy bio, Inc. \* | &nbsp;&nbsp; 39172 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 532739 |
| ACADIA Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 80050 | &nbsp;&nbsp;&nbsp;&nbsp; 1523352 |
| Agios Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 22874 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 674326 |
| Alkermes plc \* | 142024 | &nbsp;&nbsp;&nbsp;&nbsp; 4067567 |
| Amicus Therapeutics, Inc. \* | 152254 | &nbsp;&nbsp;&nbsp;&nbsp; 1985392 |
| Amneal Pharmaceuticals, Inc. \* | 447489 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 984476 |
| Amphastar Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 42687 | &nbsp;&nbsp;&nbsp;&nbsp; 1291709 |
| Arcus Biosciences, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 9375 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 202781 |
| Arrowhead Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 32572 | &nbsp;&nbsp;&nbsp;&nbsp; 1139694 |
| Beam Therapeutics, Inc. \* | &nbsp;&nbsp; 12397 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 538650 |
| BioCryst Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 37920 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 400056 |
| Blueprint Medicines Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 5574 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 260529 |
| C4 Therapeutics, Inc. \* | &nbsp;&nbsp; 40507 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 315550 |
| CareDx, Inc. \* | &nbsp;&nbsp; 31127 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 465037 |
| Catalyst Pharmaceuticals, Inc. \* | 131363 | &nbsp;&nbsp;&nbsp;&nbsp; 2034813 |
| Chinook Therapeutics, Inc. \* | &nbsp;&nbsp; 33320 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 841996 |
| Codexis, Inc. \* | 145726 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 896215 |
| Corcept Therapeutics, Inc. \* | &nbsp;&nbsp; 88465 | &nbsp;&nbsp;&nbsp;&nbsp; 2022310 |
| Cytokinetics, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 9018 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 383085 |
| Denali Therapeutics, Inc. \* | &nbsp;&nbsp; 22087 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 668573 |
| Dynavax Technologies Corp. \* | &nbsp;&nbsp; 49880 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 567634 |
| Dyne Therapeutics, Inc. \* | &nbsp;&nbsp; 25035 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 365511 |
| Eagle Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 15172 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 514938 |
| Emergent BioSolutions, Inc. \* | &nbsp;&nbsp; 38740 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 510981 |
| FibroGen, Inc. \* | &nbsp;&nbsp; 20833 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 491659 |
| Halozyme Therapeutics, Inc. \* | &nbsp;&nbsp; 29341 | &nbsp;&nbsp;&nbsp;&nbsp; 1518984 |
| Harmony Biosciences Holdings, Inc. \* | &nbsp;&nbsp; 10880 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 524090 |
| Harrow Health, Inc. \* | &nbsp;&nbsp; 75275 | &nbsp;&nbsp;&nbsp;&nbsp; 1130631 |
| Harvard Bioscience, Inc. \* | 137068 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 408463 |
| Horizon Therapeutics plc \* | &nbsp;&nbsp; 16152 | &nbsp;&nbsp;&nbsp;&nbsp; 1772197 |
| IGM Biosciences, Inc. \* | &nbsp;&nbsp; 11110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 252530 |
| ImmunoGen, Inc. \* | &nbsp;&nbsp; 46972 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 216071 |
| Inhibrx, Inc. \* | &nbsp;&nbsp; 19120 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 478000 |
| Intercept Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 96998 | &nbsp;&nbsp;&nbsp;&nbsp; 1771183 |
| Ironwood Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 75889 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 874241 |
| Jounce Therapeutics, Inc. \* | 133701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 156430 |
| Karuna Therapeutics, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 5315 | &nbsp;&nbsp;&nbsp;&nbsp; 1059758 |
| Kiniksa Pharmaceuticals Ltd., Class A \* | 125336 | &nbsp;&nbsp;&nbsp;&nbsp; 1812359 |
| Kymera Therapeutics, Inc. \* | &nbsp;&nbsp; 11109 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 415254 |
| Ligand Pharmaceuticals, Inc. \* | &nbsp;&nbsp; 14524 | &nbsp;&nbsp;&nbsp;&nbsp; 1012323 |
| Medpace Holdings, Inc. \* | &nbsp;&nbsp; 25005 | &nbsp;&nbsp;&nbsp;&nbsp; 5527855 |
| Mersana Therapeutics, Inc. \* | &nbsp;&nbsp; 57116 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 375823 |
| MiMedx Group, Inc. \* | &nbsp;&nbsp; 91031 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 352290 |
| Myriad Genetics, Inc. \* | &nbsp;&nbsp; 12753 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 251489 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| NGM Biopharmaceuticals, Inc. \* | &nbsp;&nbsp; 39957 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 209375 |
| Nkarta, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 9968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 53129 |
| Nurix Therapeutics, Inc. \* | &nbsp;&nbsp; 50141 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 616233 |
| Organogenesis Holdings, Inc. \* | 265465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 679590 |
| Phibro Animal Health Corp., Class A  | 112016 | &nbsp;&nbsp;&nbsp;&nbsp; 1725046 |
| Prestige Consumer Healthcare, Inc. \* | &nbsp;&nbsp; 30131 | &nbsp;&nbsp;&nbsp;&nbsp; 1981415 |
| Prothena Corp. plc \* | &nbsp;&nbsp;&nbsp;&nbsp; 8338 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 471514 |
| PTC Therapeutics, Inc. \* | &nbsp;&nbsp; 30085 | &nbsp;&nbsp;&nbsp;&nbsp; 1380601 |
| Repligen Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 2446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 453244 |
| Rigel Pharmaceuticals, Inc. \* | 407364 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 668077 |
| Syneos Health, Inc. \* | &nbsp;&nbsp; 48296 | &nbsp;&nbsp;&nbsp;&nbsp; 1734792 |
| TG Therapeutics, Inc. \* | &nbsp;&nbsp; 30413 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 463190 |
| Theravance Biopharma, Inc. \* | &nbsp;&nbsp; 68493 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 740409 |
| Travere Therapeutics, Inc. \* | &nbsp;&nbsp; 40336 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 903526 |
| Vanda Pharmaceuticals, Inc. \* | 196999 | &nbsp;&nbsp;&nbsp;&nbsp; 1512952 |
| Veracyte, Inc. \* | &nbsp;&nbsp; 31001 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 779055 |
| Vericel Corp. \* | &nbsp;&nbsp; 18406 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 505613 |
| Vir Biotechnology, Inc. \* | &nbsp;&nbsp; 36407 | &nbsp;&nbsp;&nbsp;&nbsp; 1075827 |
| Xencor, Inc. \* | &nbsp;&nbsp; 34439 | &nbsp;&nbsp;&nbsp;&nbsp; 1133732 |
|  |  | **60676864** |
| **Real Estate 7.0%** | **Real Estate 7.0%** | **Real Estate 7.0%** |
| Apple Hospitality REIT, Inc.  | 393403 | &nbsp;&nbsp;&nbsp;&nbsp; 6975035 |
| Armada Hoffler Properties, Inc.  | 222938 | &nbsp;&nbsp;&nbsp;&nbsp; 2826854 |
| BRT Apartments Corp.  | &nbsp;&nbsp; 98906 | &nbsp;&nbsp;&nbsp;&nbsp; 2072081 |
| CareTrust REIT, Inc.  | &nbsp;&nbsp; 38134 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 790136 |
| DiamondRock Hospitality Co.  | 107901 | &nbsp;&nbsp;&nbsp;&nbsp; 1039087 |
| EastGroup Properties, Inc.  | &nbsp;&nbsp; 26644 | &nbsp;&nbsp;&nbsp;&nbsp; 4482853 |
| eXp World Holdings, Inc.  | &nbsp;&nbsp; 55468 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 864746 |
| InvenTrust Properties Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 8608 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 214081 |
| National Storage Affiliates Trust  | &nbsp;&nbsp; 35408 | &nbsp;&nbsp;&nbsp;&nbsp; 1444646 |
| Paramount Group, Inc.  | 486337 | &nbsp;&nbsp;&nbsp;&nbsp; 3136874 |
| Piedmont Office Realty Trust, Inc., Class A  | 377224 | &nbsp;&nbsp;&nbsp;&nbsp; 3998574 |
| PotlatchDeltic Corp.  | &nbsp;&nbsp; 28440 | &nbsp;&nbsp;&nbsp;&nbsp; 1392138 |
| RPT Realty  | &nbsp;&nbsp; 92924 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 973844 |
| Ryman Hospitality Properties, Inc.  | &nbsp;&nbsp; 11628 | &nbsp;&nbsp;&nbsp;&nbsp; 1080125 |
| Sabra Health Care REIT, Inc.  | &nbsp;&nbsp; 65306 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 881631 |
| SITE Centers Corp.  | 172722 | &nbsp;&nbsp;&nbsp;&nbsp; 2357655 |
| The Necessity Retail REIT, Inc.  | 432206 | &nbsp;&nbsp;&nbsp;&nbsp; 2951967 |
| Uniti Group, Inc.  | 115959 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 764170 |
|  |  | **38246497** |
| **Retailing 2.4%** | **Retailing 2.4%** | **Retailing 2.4%** |
| AutoNation, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 4967 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 629418 |
| Build-A-Bear Workshop, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 8989 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 220770 |
| Caleres, Inc.  | &nbsp;&nbsp; 39098 | &nbsp;&nbsp;&nbsp;&nbsp; 1017330 |
| Chico's FAS, Inc. \* | &nbsp;&nbsp; 61714 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 325233 |
| Duluth Holdings, Inc., Class B \* | 119269 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 793139 |
| Group 1 Automotive, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 8879 | &nbsp;&nbsp;&nbsp;&nbsp; 1898774 |
| Macy's, Inc.  | 182154 | &nbsp;&nbsp;&nbsp;&nbsp; 4304299 |
| Revolve Group, Inc. \* | &nbsp;&nbsp; 22446 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 640609 |
| Signet Jewelers Ltd.  | &nbsp;&nbsp; 14784 | &nbsp;&nbsp;&nbsp;&nbsp; 1135559 |
| The Buckle, Inc.  | &nbsp;&nbsp; 19762 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 869528 |
| The Children's Place, Inc. \* | &nbsp;&nbsp; 28504 | &nbsp;&nbsp;&nbsp;&nbsp; 1293226 |
|  |  | **13127885** |
| **Semiconductors & Semiconductor Equipment 3.4%** | **Semiconductors & Semiconductor Equipment 3.4%** | **Semiconductors & Semiconductor Equipment 3.4%** |
| Ambarella, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 8195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 736239 |
| Amkor Technology, Inc.  | &nbsp;&nbsp; 29727 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 869812 |
| Axcelis Technologies, Inc. \* | &nbsp;&nbsp; 33722 | &nbsp;&nbsp;&nbsp;&nbsp; 3707734 |
| Diodes, Inc. \* | &nbsp;&nbsp; 18066 | &nbsp;&nbsp;&nbsp;&nbsp; 1611307 |
| Lattice Semiconductor Corp. \* | &nbsp;&nbsp; 89065 | &nbsp;&nbsp;&nbsp;&nbsp; 6750236 |
| MaxLinear, Inc. \* | &nbsp;&nbsp; 41976 | &nbsp;&nbsp;&nbsp;&nbsp; 1729411 |

---

**9**

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Semtech Corp. \* | &nbsp;&nbsp; 35771 | &nbsp;&nbsp;&nbsp;&nbsp; 1181516 |
| Synaptics, Inc. \* | &nbsp;&nbsp; 17031 | &nbsp;&nbsp;&nbsp;&nbsp; 2129386 |
|  |  | **18715641** |
| **Software & Services 7.0%** | **Software & Services 7.0%** | **Software & Services 7.0%** |
| 8x8, Inc. \* | 110988 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 522753 |
| A10 Networks, Inc.  | 162526 | &nbsp;&nbsp;&nbsp;&nbsp; 2515902 |
| Agilysys, Inc. \* | &nbsp;&nbsp; 22614 | &nbsp;&nbsp;&nbsp;&nbsp; 1889626 |
| American Software, Inc., Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 9898 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 150549 |
| Box, Inc., Class A \* | 151386 | &nbsp;&nbsp;&nbsp;&nbsp; 4842838 |
| CommVault Systems, Inc. \* | &nbsp;&nbsp; 64891 | &nbsp;&nbsp;&nbsp;&nbsp; 4038167 |
| CoreCard Corp. \* | &nbsp;&nbsp; 25317 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 847613 |
| Domo, Inc., Class B \* | &nbsp;&nbsp; 65005 | &nbsp;&nbsp;&nbsp;&nbsp; 1008228 |
| eGain Corp. \* | 193849 | &nbsp;&nbsp;&nbsp;&nbsp; 1884212 |
| EngageSmart, Inc. \* | &nbsp;&nbsp; 26596 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 523941 |
| EVERTEC, Inc.  | &nbsp;&nbsp; 19788 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 730969 |
| ExlService Holdings, Inc. \* | &nbsp;&nbsp; 16836 | &nbsp;&nbsp;&nbsp;&nbsp; 2872222 |
| LiveRamp Holdings, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 8203 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 219512 |
| Model N, Inc. \* | &nbsp;&nbsp; 27920 | &nbsp;&nbsp;&nbsp;&nbsp; 1107307 |
| Progress Software Corp.  | &nbsp;&nbsp; 18295 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 970367 |
| Qualys, Inc. \* | &nbsp;&nbsp; 44389 | &nbsp;&nbsp;&nbsp;&nbsp; 5120715 |
| Sprout Social, Inc., Class A \* | &nbsp;&nbsp; 38659 | &nbsp;&nbsp;&nbsp;&nbsp; 2473016 |
| Tenable Holdings, Inc. \* | &nbsp;&nbsp; 16251 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 653778 |
| The Hackett Group, Inc.  | &nbsp;&nbsp; 82646 | &nbsp;&nbsp;&nbsp;&nbsp; 1826477 |
| Unisys Corp. \* | 105652 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 571577 |
| Verra Mobility Corp. \* | &nbsp;&nbsp; 46903 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 723713 |
| Workiva, Inc. \* | &nbsp;&nbsp; 27481 | &nbsp;&nbsp;&nbsp;&nbsp; 2377931 |
| Zuora, Inc., Class A \* | &nbsp;&nbsp; 63916 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 506215 |
|  |  | **38377628** |
| **Technology Hardware & Equipment 3.8%** | **Technology Hardware & Equipment 3.8%** | **Technology Hardware & Equipment 3.8%** |
| Avid Technology, Inc. \* | &nbsp;&nbsp; 80856 | &nbsp;&nbsp;&nbsp;&nbsp; 2450745 |
| Belden, Inc.  | &nbsp;&nbsp; 31827 | &nbsp;&nbsp;&nbsp;&nbsp; 2580851 |
| Calix, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 7357 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 387272 |
| Cambium Networks Corp. \* | &nbsp;&nbsp; 33829 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 724955 |
| Casa Systems, Inc. \* | 132875 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 454433 |
| CommScope Holding Co., Inc. \* | 103478 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 869215 |
| Extreme Networks, Inc. \* | 163483 | &nbsp;&nbsp;&nbsp;&nbsp; 2947599 |
| Fabrinet \* | &nbsp;&nbsp; 15169 | &nbsp;&nbsp;&nbsp;&nbsp; 1997151 |
| Sanmina Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 8821 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 537464 |
| Super Micro Computer, Inc. \* | &nbsp;&nbsp; 22120 | &nbsp;&nbsp;&nbsp;&nbsp; 1599940 |
| Vishay Intertechnology, Inc.  | 281306 | &nbsp;&nbsp;&nbsp;&nbsp; 6439094 |
|  |  | **20988719** |
| **Telecommunication Services 1.6%** | **Telecommunication Services 1.6%** | **Telecommunication Services 1.6%** |
| Cogent Communications Holdings, Inc.  | &nbsp;&nbsp; 16173 | &nbsp;&nbsp;&nbsp;&nbsp; 1108983 |
| Iridium Communications, Inc. \* | &nbsp;&nbsp; 60487 | &nbsp;&nbsp;&nbsp;&nbsp; 3619542 |
| Liberty Latin America Ltd., Class A \* | 353075 | &nbsp;&nbsp;&nbsp;&nbsp; 3474258 |
| Ooma, Inc. \* | &nbsp;&nbsp; 32459 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 466436 |
|  |  | **8669219** |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **Transportation 1.3%** | **Transportation 1.3%** | **Transportation 1.3%** |
| ArcBest Corp.  | &nbsp;&nbsp; 10697 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 892665 |
| Forward Air Corp.  | &nbsp;&nbsp; 31808 | &nbsp;&nbsp;&nbsp;&nbsp; 3430493 |
| Hub Group, Inc., Class A \* | &nbsp;&nbsp; 11981 | &nbsp;&nbsp;&nbsp;&nbsp; 1021620 |
| Matson, Inc.  | &nbsp;&nbsp; 21713 | &nbsp;&nbsp;&nbsp;&nbsp; 1435663 |
| Radiant Logistics, Inc. \* | &nbsp;&nbsp; 69136 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 387853 |
|  |  | **7168294** |
| **Utilities 1.9%** | **Utilities 1.9%** | **Utilities 1.9%** |
| Chesapeake Utilities Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 3802 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 479356 |
| Clearway Energy, Inc., Class A  | &nbsp;&nbsp; 97753 | &nbsp;&nbsp;&nbsp;&nbsp; 3132984 |
| Consolidated Water Co., Ltd.  | &nbsp;&nbsp; 35962 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 526843 |
| Genie Energy Ltd., Class B  | &nbsp;&nbsp; 89885 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 984241 |
| Montauk Renewables, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 9494 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 105478 |
| Otter Tail Corp.  | &nbsp;&nbsp; 63730 | &nbsp;&nbsp;&nbsp;&nbsp; 4088279 |
| Via Renewables, Inc.  | 192739 | &nbsp;&nbsp;&nbsp;&nbsp; 1293279 |
|  |  | **10610460** |
| **Total Common Stocks**<br> **(Cost $500,626,045)** | **Total Common Stocks**<br> **(Cost $500,626,045)** | **548996681** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **SHORT-TERM INVESTMENTS** 0.1% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.1% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 0.1% OF NET ASSETS |
| **Money Market Funds 0.1%** | **Money Market Funds 0.1%** | **Money Market Funds 0.1%** |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional U.S. Government <br> Money Market Fund, Premier Class <br> 4.18% *(c)(d)*<br>| 240488 | **240488** |
| **Total Short-Term Investments**<br> **(Cost $240,488)** | **Total Short-Term Investments**<br> **(Cost $240,488)** | **240488** |
| **Total Investments in Securities**<br> **(Cost $500,866,533)** | **Total Investments in Securities**<br> **(Cost $500,866,533)** | **549237169** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

*(a)* All or a portion of this security is on loan. Securities on loan were valued at $227,941. 

*(b)* Fair-valued by management using significant unobservable inputs in accordance with procedures approved by the fund's Board of Trustees. 

*(c)* The rate shown is the annualized 7-day yield.

*(d)* Security purchased with cash collateral received for securities on loan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

REIT — Real Estate Investment Trust

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

**10** 

------

Schwab Small-Cap Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

The following is a summary of the inputs used to value the fund's investments as of January 31, 2023:

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $513207184 | $— | $— | $513207184 |
| &nbsp;&nbsp;&nbsp;&nbsp; Health Care Equipment & Services | &nbsp;&nbsp;&nbsp;&nbsp; 35789497 | &nbsp;&nbsp; — | &nbsp;&nbsp; 0<sup>\*</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp; 35789497 |
| Short-Term Investments<sup>1</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 240488 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 240488 |
| **Total** | **$549237169** | **$—** | **$0**<sup>\*</sup> <br>| **$549237169** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>\*</sup> Level 3 amount shown includes securities determined to have no value at January 31, 2023.

<sup>1</sup> As categorized in the Portfolio Holdings.

Fund investments in mutual funds are classified as Level 1, without consideration to the classification level of the underlying securities held by the mutual funds, which could be Level 1, Level 2 or Level 3.

**11**

------

Schwab Capital Trust <br>Schwab Health Care Fund

------

**Portfolio Holdings** as of January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following are the portfolio holdings as of the report date. For more information, please refer to the fund's semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 99.9% OF NET ASSETS | **COMMON STOCKS** 99.9% OF NET ASSETS | **COMMON STOCKS** 99.9% OF NET ASSETS |
| **Australia 0.7%** | **Australia 0.7%** | **Australia 0.7%** |
| Ansell Ltd.  | &nbsp;&nbsp;&nbsp; 210040 | &nbsp;&nbsp;&nbsp;&nbsp; 4197766 |
| Cochlear Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6544 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 988645 |
| Sonic Healthcare Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 41427 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 927864 |
|  |  | **6114275** |
| **Denmark 3.3%** | **Denmark 3.3%** | **Denmark 3.3%** |
| Coloplast A/S, Class B  | &nbsp;&nbsp;&nbsp;&nbsp; 20897 | &nbsp;&nbsp;&nbsp;&nbsp; 2522987 |
| Novo Nordisk A/S, Class B  | &nbsp;&nbsp;&nbsp; 185711 | &nbsp;&nbsp; 25700502 |
|  |  | **28223489** |
| **France 2.4%** | **France 2.4%** | **France 2.4%** |
| Ipsen S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 57884 | &nbsp;&nbsp;&nbsp;&nbsp; 6079846 |
| Sanofi  | &nbsp;&nbsp;&nbsp; 146424 | &nbsp;&nbsp; 14338486 |
|  |  | **20418332** |
| **Hong Kong 0.7%** | **Hong Kong 0.7%** | **Hong Kong 0.7%** |
| CSPC Pharmaceutical Group Ltd.  | 4122000 | &nbsp;&nbsp;&nbsp;&nbsp; 4699915 |
| Hansoh Pharmaceutical Group Co., Ltd.  | &nbsp;&nbsp;&nbsp; 344000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 704069 |
| &nbsp;&nbsp;&nbsp;&nbsp; The United Laboratories International <br> Holdings Ltd. <br>| &nbsp;&nbsp;&nbsp; 752000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 497857 |
|  |  | **5901841** |
| **Ireland 2.5%** | **Ireland 2.5%** | **Ireland 2.5%** |
| Medtronic plc  | &nbsp;&nbsp;&nbsp; 256083 | **21431586** |
| **Japan 2.6%** | **Japan 2.6%** | **Japan 2.6%** |
| Astellas Pharma, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 14600 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 214914 |
| Chugai Pharmaceutical Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 25000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 648127 |
| Hoya Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 96700 | &nbsp;&nbsp; 10634284 |
| JEOL Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 45000 | &nbsp;&nbsp;&nbsp;&nbsp; 1321381 |
| Nihon Kohden Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 65700 | &nbsp;&nbsp;&nbsp;&nbsp; 1726004 |
| Ono Pharmaceutical Co., Ltd.  | &nbsp;&nbsp;&nbsp; 360100 | &nbsp;&nbsp;&nbsp;&nbsp; 7813696 |
|  |  | **22358406** |
| **Republic of Korea 0.2%** | **Republic of Korea 0.2%** | **Republic of Korea 0.2%** |
| Celltrion, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6558 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 865532 |
| Dentium Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6593 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 633639 |
|  |  | **1499171** |
| **Switzerland 4.5%** | **Switzerland 4.5%** | **Switzerland 4.5%** |
| Lonza Group AG  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3096 | &nbsp;&nbsp;&nbsp;&nbsp; 1766086 |
| Novartis AG  | &nbsp;&nbsp;&nbsp;&nbsp; 98886 | &nbsp;&nbsp;&nbsp;&nbsp; 8940188 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Roche Holding AG  | &nbsp;&nbsp;&nbsp;&nbsp; 60988 | &nbsp;&nbsp; 19038647 |
| Sonova Holding AG  | &nbsp;&nbsp;&nbsp;&nbsp; 32377 | &nbsp;&nbsp;&nbsp;&nbsp; 8096570 |
|  |  | **37841491** |
| **Taiwan 0.1%** | **Taiwan 0.1%** | **Taiwan 0.1%** |
| TTY Biopharm Co., Ltd.  | &nbsp;&nbsp;&nbsp; 150000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 388631 |
| Universal Vision Biotechnology Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 27000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 294569 |
|  |  | **683200** |
| **United Kingdom 4.1%** | **United Kingdom 4.1%** | **United Kingdom 4.1%** |
| AstraZeneca plc  | &nbsp;&nbsp;&nbsp; 147669 | &nbsp;&nbsp; 19346478 |
| GSK plc  | &nbsp;&nbsp;&nbsp; 858563 | &nbsp;&nbsp; 15080672 |
|  |  | **34427150** |
| **United States 78.8%** | **United States 78.8%** | **United States 78.8%** |
| Abbott Laboratories  | &nbsp;&nbsp;&nbsp; 276358 | &nbsp;&nbsp; 30551377 |
| AbbVie, Inc.  | &nbsp;&nbsp;&nbsp; 105553 | &nbsp;&nbsp; 15595456 |
| Agilent Technologies, Inc.  | &nbsp;&nbsp;&nbsp; 126206 | &nbsp;&nbsp; 19193408 |
| Amgen, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 86365 | &nbsp;&nbsp; 21798526 |
| AMN Healthcare Services, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 24790 | &nbsp;&nbsp;&nbsp;&nbsp; 2375874 |
| Avanos Medical, Inc. \* | &nbsp;&nbsp;&nbsp; 118742 | &nbsp;&nbsp;&nbsp;&nbsp; 3638255 |
| Axonics, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 22200 | &nbsp;&nbsp;&nbsp;&nbsp; 1363080 |
| Biogen, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 15869 | &nbsp;&nbsp;&nbsp;&nbsp; 4616292 |
| BioMarin Pharmaceutical, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 52298 | &nbsp;&nbsp;&nbsp;&nbsp; 6032574 |
| Bio-Techne Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 62396 | &nbsp;&nbsp;&nbsp;&nbsp; 4970465 |
| Bristol-Myers Squibb Co.  | &nbsp;&nbsp;&nbsp; 433163 | &nbsp;&nbsp; 31469292 |
| Catalyst Pharmaceuticals, Inc. \* | &nbsp;&nbsp;&nbsp; 364830 | &nbsp;&nbsp;&nbsp;&nbsp; 5651217 |
| Cigna Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 72444 | &nbsp;&nbsp; 22940841 |
| CVS Health Corp.  | &nbsp;&nbsp;&nbsp; 283439 | &nbsp;&nbsp; 25004989 |
| Danaher Corp.  | &nbsp;&nbsp;&nbsp; 110440 | &nbsp;&nbsp; 29198127 |
| Edwards Lifesciences Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 32066 | &nbsp;&nbsp;&nbsp;&nbsp; 2459462 |
| Elevance Health, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 33332 | &nbsp;&nbsp; 16665667 |
| Eli Lilly & Co.  | &nbsp;&nbsp;&nbsp;&nbsp; 68503 | &nbsp;&nbsp; 23575307 |
| Gilead Sciences, Inc.  | &nbsp;&nbsp;&nbsp; 317665 | &nbsp;&nbsp; 26664800 |
| Halozyme Therapeutics, Inc. \* | &nbsp;&nbsp;&nbsp; 180847 | &nbsp;&nbsp;&nbsp;&nbsp; 9362449 |
| Hologic, Inc. \* | &nbsp;&nbsp;&nbsp; 109039 | &nbsp;&nbsp;&nbsp;&nbsp; 8872503 |
| Humana, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 22927 | &nbsp;&nbsp; 11731746 |
| Inmode Ltd. \* | &nbsp;&nbsp;&nbsp;&nbsp; 19900 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 697495 |
| Integra LifeSciences Holdings Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 51235 | &nbsp;&nbsp;&nbsp;&nbsp; 2935766 |
| Intercept Pharmaceuticals, Inc. \* | &nbsp;&nbsp;&nbsp; 109500 | &nbsp;&nbsp;&nbsp;&nbsp; 1999470 |
| Intuitive Surgical, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 32459 | &nbsp;&nbsp;&nbsp;&nbsp; 7974852 |
| IQVIA Holdings, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 62892 | &nbsp;&nbsp; 14428054 |
| Jazz Pharmaceuticals plc \* | &nbsp;&nbsp;&nbsp;&nbsp; 19055 | &nbsp;&nbsp;&nbsp;&nbsp; 2985156 |
| Johnson & Johnson  | &nbsp;&nbsp;&nbsp; 248067 | &nbsp;&nbsp; 40539109 |
| Lantheus Holdings, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 30993 | &nbsp;&nbsp;&nbsp;&nbsp; 1782098 |
| Medpace Holdings, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 15000 | &nbsp;&nbsp;&nbsp;&nbsp; 3316050 |
| Merck & Co., Inc.  | &nbsp;&nbsp;&nbsp; 386992 | &nbsp;&nbsp; 41566811 |
| Mettler-Toledo International, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8493 | &nbsp;&nbsp; 13019090 |
| Moderna, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 72238 | &nbsp;&nbsp; 12718222 |
| Molina Healthcare, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9009 | &nbsp;&nbsp;&nbsp;&nbsp; 2809276 |
| NextGen Healthcare, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 30400 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 578208 |
| NuVasive, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 97199 | &nbsp;&nbsp;&nbsp;&nbsp; 4432274 |
| PerkinElmer, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 17181 | &nbsp;&nbsp;&nbsp;&nbsp; 2362903 |

---

**12** 

------

Schwab Health Care Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Pfizer, Inc.  | &nbsp;&nbsp;&nbsp; 443951 | &nbsp;&nbsp; 19604876 |
| Phibro Animal Health Corp., Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 28238 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 434865 |
| Prestige Consumer Healthcare, Inc. \* | &nbsp;&nbsp;&nbsp; 105946 | &nbsp;&nbsp;&nbsp;&nbsp; 6967009 |
| QIAGEN N.V. \* | &nbsp;&nbsp;&nbsp;&nbsp; 48506 | &nbsp;&nbsp;&nbsp;&nbsp; 2376794 |
| Quest Diagnostics, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3800 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 564224 |
| Regeneron Pharmaceuticals, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 13850 | &nbsp;&nbsp; 10504810 |
| STERIS plc  | &nbsp;&nbsp;&nbsp;&nbsp; 15388 | &nbsp;&nbsp;&nbsp;&nbsp; 3177776 |
| Thermo Fisher Scientific, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 32921 | &nbsp;&nbsp; 18775834 |
| United Therapeutics Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 26883 | &nbsp;&nbsp;&nbsp;&nbsp; 7074799 |
| UnitedHealth Group, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 93193 | &nbsp;&nbsp; 46521014 |
| Veracyte, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 89093 | &nbsp;&nbsp;&nbsp;&nbsp; 2238907 |
| Vertex Pharmaceuticals, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 74411 | &nbsp;&nbsp; 24042194 |
| Vir Biotechnology, Inc. \* | &nbsp;&nbsp;&nbsp; 135645 | &nbsp;&nbsp;&nbsp;&nbsp; 4008310 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Waters Corp. \* | &nbsp;&nbsp;&nbsp;&nbsp; 37131 | &nbsp;&nbsp; 12200504 |
| Zimmer Biomet Holdings, Inc.  | &nbsp;&nbsp;&nbsp; 115912 | &nbsp;&nbsp; 14760234 |
| Zoetis, Inc.  | &nbsp;&nbsp;&nbsp; 117345 | &nbsp;&nbsp; 19419424 |
|  |  | **670548115** |
| **Total Common Stocks**<br> **(Cost $570,523,819)** | **Total Common Stocks**<br> **(Cost $570,523,819)** | **849447056** |
| **Total Investments in Securities**<br> **(Cost $570,523,819)** | **Total Investments in Securities**<br> **(Cost $570,523,819)** | **849447056** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

\* Non-income producing security.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of January 31, 2023:

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| $691979701 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $— | $— | $691979701 |
| &nbsp;&nbsp;&nbsp;&nbsp; Australia | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6114275 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6114275 |
| &nbsp;&nbsp;&nbsp;&nbsp; Denmark | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 28223489 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 28223489 |
| &nbsp;&nbsp;&nbsp;&nbsp; France | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 20418332 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 20418332 |
| &nbsp;&nbsp;&nbsp;&nbsp; Hong Kong | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5901841 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5901841 |
| &nbsp;&nbsp;&nbsp;&nbsp; Japan | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 22358406 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 22358406 |
| &nbsp;&nbsp;&nbsp;&nbsp; Republic of Korea | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1499171 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1499171 |
| &nbsp;&nbsp;&nbsp;&nbsp; Switzerland | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 37841491 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 37841491 |
| &nbsp;&nbsp;&nbsp;&nbsp; Taiwan | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 683200 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 683200 |
| &nbsp;&nbsp;&nbsp;&nbsp; United Kingdom | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 34427150 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 34427150 |
| **Total** | **$691979701** | **$157467355** | **$—** | **$849447056** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

**13**

------

Schwab Capital Trust <br>Schwab International Core Equity Fund

------

**Portfolio Holdings** as of January 31, 2023 (Unaudited)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

The following are the portfolio holdings as of the report date. For more information, please refer to the fund's semiannual or annual shareholder reports. You can also obtain this information at no cost by calling 1-866-414-6349 or by sending an email request to orders@mysummaryprospectus.com.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| **COMMON STOCKS** 100.8% OF NET ASSETS | **COMMON STOCKS** 100.8% OF NET ASSETS | **COMMON STOCKS** 100.8% OF NET ASSETS |
| **Australia 9.3%** | **Australia 9.3%** | **Australia 9.3%** |
| ANZ Group Holdings Ltd.  | &nbsp;&nbsp;&nbsp; 206416 | &nbsp;&nbsp;&nbsp;&nbsp; 3673460 |
| Aristocrat Leisure Ltd.  | &nbsp;&nbsp;&nbsp; 195174 | &nbsp;&nbsp;&nbsp;&nbsp; 4712130 |
| BHP Group Ltd.  | &nbsp;&nbsp;&nbsp; 341183 | &nbsp;&nbsp; 11948956 |
| Commonwealth Bank of Australia  | &nbsp;&nbsp;&nbsp;&nbsp; 24640 | &nbsp;&nbsp;&nbsp;&nbsp; 1923449 |
| Computershare Ltd.  | &nbsp;&nbsp;&nbsp; 154081 | &nbsp;&nbsp;&nbsp;&nbsp; 2595009 |
| Helia Group Ltd.  | &nbsp;&nbsp;&nbsp; 321522 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 637447 |
| Iluka Resources Ltd.  | &nbsp;&nbsp;&nbsp; 359827 | &nbsp;&nbsp;&nbsp;&nbsp; 2768752 |
| JB Hi-Fi Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 30860 | &nbsp;&nbsp;&nbsp;&nbsp; 1061044 |
| QBE Insurance Group Ltd.  | &nbsp;&nbsp;&nbsp; 176098 | &nbsp;&nbsp;&nbsp;&nbsp; 1718173 |
| Rio Tinto Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 78202 | &nbsp;&nbsp;&nbsp;&nbsp; 7017633 |
| Sonic Healthcare Ltd.  | &nbsp;&nbsp;&nbsp; 147750 | &nbsp;&nbsp;&nbsp;&nbsp; 3309238 |
| South32 Ltd.  | 1131324 | &nbsp;&nbsp;&nbsp;&nbsp; 3630338 |
| Suncorp Group Ltd.  | &nbsp;&nbsp;&nbsp; 316867 | &nbsp;&nbsp;&nbsp;&nbsp; 2816739 |
| Technology One Ltd.  | &nbsp;&nbsp;&nbsp; 239762 | &nbsp;&nbsp;&nbsp;&nbsp; 2478995 |
|  |  | **50291363** |
| **Austria 0.9%** | **Austria 0.9%** | **Austria 0.9%** |
| Erste Group Bank AG  | &nbsp;&nbsp;&nbsp;&nbsp; 33073 | &nbsp;&nbsp;&nbsp;&nbsp; 1254926 |
| Wienerberger AG  | &nbsp;&nbsp;&nbsp; 126459 | &nbsp;&nbsp;&nbsp;&nbsp; 3802748 |
|  |  | **5057674** |
| **Canada 1.9%** | **Canada 1.9%** | **Canada 1.9%** |
| Cenovus Energy, Inc.  | &nbsp;&nbsp;&nbsp; 108000 | &nbsp;&nbsp;&nbsp;&nbsp; 2157484 |
| CGI, Inc. \* | &nbsp;&nbsp;&nbsp;&nbsp; 38509 | &nbsp;&nbsp;&nbsp;&nbsp; 3300565 |
| Loblaw Cos., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 37160 | &nbsp;&nbsp;&nbsp;&nbsp; 3329053 |
| Suncor Energy, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 45200 | &nbsp;&nbsp;&nbsp;&nbsp; 1568777 |
|  |  | **10355879** |
| **China 0.4%** | **China 0.4%** | **China 0.4%** |
| BAIC Motor Corp., Ltd., H Shares  | 4150000 | &nbsp;&nbsp;&nbsp;&nbsp; 1273882 |
| Dongfang Electric Corp., Ltd., H Shares  | &nbsp;&nbsp;&nbsp; 386400 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 690126 |
|  |  | **1964008** |
| **Denmark 4.5%** | **Denmark 4.5%** | **Denmark 4.5%** |
| AP Moller - Maersk A/S, Class B  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1446 | &nbsp;&nbsp;&nbsp;&nbsp; 3145472 |
| Carlsberg A/S, Class B  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7207 | &nbsp;&nbsp;&nbsp;&nbsp; 1023117 |
| Jyske Bank A/S \* | &nbsp;&nbsp;&nbsp;&nbsp; 23452 | &nbsp;&nbsp;&nbsp;&nbsp; 1691437 |
| Novo Nordisk A/S, Class B  | &nbsp;&nbsp;&nbsp; 132169 | &nbsp;&nbsp; 18290837 |
|  |  | **24150863** |
| **France 15.0%** | **France 15.0%** | **France 15.0%** |
| BNP Paribas S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 35323 | &nbsp;&nbsp;&nbsp;&nbsp; 2426050 |
| Capgemini SE  | &nbsp;&nbsp;&nbsp;&nbsp; 14761 | &nbsp;&nbsp;&nbsp;&nbsp; 2801425 |
| Cie de Saint-Gobain  | &nbsp;&nbsp;&nbsp; 118432 | &nbsp;&nbsp;&nbsp;&nbsp; 6801687 |
| Dassault Aviation S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 20847 | &nbsp;&nbsp;&nbsp;&nbsp; 3559902 |
| Eiffage S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 68593 | &nbsp;&nbsp;&nbsp;&nbsp; 7326457 |
| Engie S.A.  | &nbsp;&nbsp;&nbsp; 476133 | &nbsp;&nbsp;&nbsp;&nbsp; 6761024 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Hermes International  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1212 | &nbsp;&nbsp;&nbsp;&nbsp; 2268269 |
| Ipsen S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 40575 | &nbsp;&nbsp;&nbsp;&nbsp; 4261795 |
| L'Oreal S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 17159 | &nbsp;&nbsp;&nbsp;&nbsp; 7085150 |
| LVMH Moet Hennessy Louis Vuitton SE  | &nbsp;&nbsp;&nbsp;&nbsp; 21500 | &nbsp;&nbsp; 18768976 |
| Sanofi  | &nbsp;&nbsp;&nbsp;&nbsp; 22454 | &nbsp;&nbsp;&nbsp;&nbsp; 2198795 |
| Schneider Electric SE  | &nbsp;&nbsp;&nbsp;&nbsp; 12822 | &nbsp;&nbsp;&nbsp;&nbsp; 2079928 |
| Societe Generale S.A.  | &nbsp;&nbsp;&nbsp; 111673 | &nbsp;&nbsp;&nbsp;&nbsp; 3324122 |
| Thales S.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 10235 | &nbsp;&nbsp;&nbsp;&nbsp; 1353674 |
| TotalEnergies SE  | &nbsp;&nbsp;&nbsp; 167289 | &nbsp;&nbsp; 10341932 |
|  |  | **81359186** |
| **Germany 7.5%** | **Germany 7.5%** | **Germany 7.5%** |
| Allianz SE  | &nbsp;&nbsp;&nbsp;&nbsp; 12577 | &nbsp;&nbsp;&nbsp;&nbsp; 3007335 |
| Bayerische Motoren Werke AG  | &nbsp;&nbsp;&nbsp;&nbsp; 42033 | &nbsp;&nbsp;&nbsp;&nbsp; 4281676 |
| Deutsche Telekom AG  | &nbsp;&nbsp;&nbsp; 407052 | &nbsp;&nbsp;&nbsp;&nbsp; 9068630 |
| Hugo Boss AG  | &nbsp;&nbsp;&nbsp;&nbsp; 52088 | &nbsp;&nbsp;&nbsp;&nbsp; 3537304 |
| K+S AG  | &nbsp;&nbsp;&nbsp; 154673 | &nbsp;&nbsp;&nbsp;&nbsp; 3702321 |
| Mercedes-Benz Group AG  | &nbsp;&nbsp;&nbsp;&nbsp; 88253 | &nbsp;&nbsp;&nbsp;&nbsp; 6567085 |
| Merck KGaA  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9645 | &nbsp;&nbsp;&nbsp;&nbsp; 2013183 |
| Siemens AG  | &nbsp;&nbsp;&nbsp;&nbsp; 53391 | &nbsp;&nbsp;&nbsp;&nbsp; 8339956 |
|  |  | **40517490** |
| **Greece 0.6%** | **Greece 0.6%** | **Greece 0.6%** |
| &nbsp;&nbsp;&nbsp;&nbsp; Hellenic Telecommunications Organization <br> S.A. <br>| &nbsp;&nbsp;&nbsp; 204286 | **3220414** |
| **Hong Kong 2.7%** | **Hong Kong 2.7%** | **Hong Kong 2.7%** |
| AIA Group Ltd.  | &nbsp;&nbsp;&nbsp; 451600 | &nbsp;&nbsp;&nbsp;&nbsp; 5106532 |
| CK Asset Holdings Ltd.  | &nbsp;&nbsp;&nbsp; 168000 | &nbsp;&nbsp;&nbsp;&nbsp; 1074110 |
| CK Infrastructure Holdings Ltd.  | &nbsp;&nbsp;&nbsp; 249000 | &nbsp;&nbsp;&nbsp;&nbsp; 1385324 |
| Hong Kong Exchanges & Clearing Ltd.  | &nbsp;&nbsp;&nbsp; 102300 | &nbsp;&nbsp;&nbsp;&nbsp; 4601206 |
| Sino Land Co., Ltd.  | &nbsp;&nbsp;&nbsp; 854585 | &nbsp;&nbsp;&nbsp;&nbsp; 1110514 |
| SITC International Holdings Co., Ltd.  | &nbsp;&nbsp;&nbsp; 723000 | &nbsp;&nbsp;&nbsp;&nbsp; 1579465 |
|  |  | **14857151** |
| **Italy 2.1%** | **Italy 2.1%** | **Italy 2.1%** |
| Assicurazioni Generali S.p.A.  | &nbsp;&nbsp;&nbsp;&nbsp; 61244 | &nbsp;&nbsp;&nbsp;&nbsp; 1195563 |
| Eni S.p.A.  | &nbsp;&nbsp;&nbsp; 223071 | &nbsp;&nbsp;&nbsp;&nbsp; 3432667 |
| UniCredit S.p.A.  | &nbsp;&nbsp;&nbsp; 187662 | &nbsp;&nbsp;&nbsp;&nbsp; 3665253 |
| Unipol Gruppo S.p.A.  | &nbsp;&nbsp;&nbsp; 613201 | &nbsp;&nbsp;&nbsp;&nbsp; 3211556 |
|  |  | **11505039** |
| **Japan 19.7%** | **Japan 19.7%** | **Japan 19.7%** |
| Advantest Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 29000 | &nbsp;&nbsp;&nbsp;&nbsp; 2078748 |
| Bandai Namco Holdings, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 29000 | &nbsp;&nbsp;&nbsp;&nbsp; 1939338 |
| Central Glass Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 74000 | &nbsp;&nbsp;&nbsp;&nbsp; 1634204 |
| Dexerials Corp.  | &nbsp;&nbsp;&nbsp; 103700 | &nbsp;&nbsp;&nbsp;&nbsp; 2216679 |
| DMG Mori Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 83900 | &nbsp;&nbsp;&nbsp;&nbsp; 1281507 |
| Electric Power Development Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 76000 | &nbsp;&nbsp;&nbsp;&nbsp; 1226528 |
| Fujikura Ltd.  | &nbsp;&nbsp;&nbsp; 208800 | &nbsp;&nbsp;&nbsp;&nbsp; 1587164 |
| Honda Motor Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 70000 | &nbsp;&nbsp;&nbsp;&nbsp; 1731556 |

---

**14** 

------

Schwab International Core Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| Hosiden Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 89100 | &nbsp;&nbsp;&nbsp;&nbsp; 1080757 |
| Hoya Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 52003 | &nbsp;&nbsp;&nbsp;&nbsp; 5718870 |
| Ibiden Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 51900 | &nbsp;&nbsp;&nbsp;&nbsp; 2025599 |
| Inpex Corp.  | &nbsp;&nbsp;&nbsp; 267000 | &nbsp;&nbsp;&nbsp;&nbsp; 2933967 |
| Invincible Investment Corp.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5460 | &nbsp;&nbsp;&nbsp;&nbsp; 2328533 |
| Japan Tobacco, Inc.  | &nbsp;&nbsp;&nbsp; 344982 | &nbsp;&nbsp;&nbsp;&nbsp; 7034840 |
| KDDI Corp.  | &nbsp;&nbsp;&nbsp; 137200 | &nbsp;&nbsp;&nbsp;&nbsp; 4286599 |
| Keyence Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 12900 | &nbsp;&nbsp;&nbsp;&nbsp; 5938757 |
| Lawson, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 21100 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 843710 |
| Marubeni Corp.  | &nbsp;&nbsp;&nbsp; 241000 | &nbsp;&nbsp;&nbsp;&nbsp; 2956727 |
| Meitec Corp.  | &nbsp;&nbsp;&nbsp; 149400 | &nbsp;&nbsp;&nbsp;&nbsp; 2810467 |
| Mitsubishi Heavy Industries Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 20000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 784199 |
| NGK Spark Plug Co., Ltd.  | &nbsp;&nbsp;&nbsp; 114000 | &nbsp;&nbsp;&nbsp;&nbsp; 2227687 |
| Nintendo Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 20200 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 875827 |
| Nippon Building Fund, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 799 | &nbsp;&nbsp;&nbsp;&nbsp; 3491920 |
| Nippon Gas Co., Ltd.  | &nbsp;&nbsp;&nbsp; 130700 | &nbsp;&nbsp;&nbsp;&nbsp; 2086146 |
| Ono Pharmaceutical Co., Ltd.  | &nbsp;&nbsp;&nbsp; 126200 | &nbsp;&nbsp;&nbsp;&nbsp; 2738374 |
| ORIX Corp.  | &nbsp;&nbsp;&nbsp; 399700 | &nbsp;&nbsp;&nbsp;&nbsp; 7027917 |
| Recruit Holdings Co., Ltd.  | &nbsp;&nbsp;&nbsp; 111200 | &nbsp;&nbsp;&nbsp;&nbsp; 3576221 |
| Sankyu, Inc.  | &nbsp;&nbsp;&nbsp; 114200 | &nbsp;&nbsp;&nbsp;&nbsp; 4487119 |
| Seino Holdings Co., Ltd.  | &nbsp;&nbsp;&nbsp; 282000 | &nbsp;&nbsp;&nbsp;&nbsp; 2816328 |
| Senko Group Holdings Co., Ltd.  | &nbsp;&nbsp;&nbsp; 168000 | &nbsp;&nbsp;&nbsp;&nbsp; 1299455 |
| Shimamura Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 14400 | &nbsp;&nbsp;&nbsp;&nbsp; 1350778 |
| Shin-Etsu Chemical Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 59100 | &nbsp;&nbsp;&nbsp;&nbsp; 8712700 |
| Sumitomo Forestry Co., Ltd.  | &nbsp;&nbsp;&nbsp; 102000 | &nbsp;&nbsp;&nbsp;&nbsp; 1907145 |
| Sumitomo Mitsui Financial Group, Inc.  | &nbsp;&nbsp;&nbsp;&nbsp; 59600 | &nbsp;&nbsp;&nbsp;&nbsp; 2590279 |
| Suntory Beverage & Food Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 76500 | &nbsp;&nbsp;&nbsp;&nbsp; 2583232 |
| Takeda Pharmaceutical Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 78500 | &nbsp;&nbsp;&nbsp;&nbsp; 2467833 |
| Tokyotokeiba Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 44800 | &nbsp;&nbsp;&nbsp;&nbsp; 1335520 |
| Tokyu REIT, Inc. *(a)* | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1601 | &nbsp;&nbsp;&nbsp;&nbsp; 2412426 |
| Yakult Honsha Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 642491 |
|  |  | **107068147** |
| **Netherlands 5.5%** | **Netherlands 5.5%** | **Netherlands 5.5%** |
| ASML Holding N.V.  | &nbsp;&nbsp;&nbsp;&nbsp; 20359 | &nbsp;&nbsp; 13470484 |
| Koninklijke Ahold Delhaize N.V.  | &nbsp;&nbsp;&nbsp; 212643 | &nbsp;&nbsp;&nbsp;&nbsp; 6346748 |
| OCI N.V. \* | &nbsp;&nbsp;&nbsp;&nbsp; 65766 | &nbsp;&nbsp;&nbsp;&nbsp; 2238704 |
| Stellantis N.V.  | &nbsp;&nbsp;&nbsp; 148492 | &nbsp;&nbsp;&nbsp;&nbsp; 2334441 |
| Wolters Kluwer N.V.  | &nbsp;&nbsp;&nbsp;&nbsp; 49762 | &nbsp;&nbsp;&nbsp;&nbsp; 5425204 |
|  |  | **29815581** |
| **Norway 0.9%** | **Norway 0.9%** | **Norway 0.9%** |
| Equinor A.S.A.  | &nbsp;&nbsp;&nbsp; 156233 | **4761457** |
| **Republic of Korea 1.1%** | **Republic of Korea 1.1%** | **Republic of Korea 1.1%** |
| Kia Corp.  | &nbsp;&nbsp;&nbsp;&nbsp; 52747 | &nbsp;&nbsp;&nbsp;&nbsp; 2873757 |
| Samsung Electro-Mechanics Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6004 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 701225 |
| Samsung Electronics Co., Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 51704 | &nbsp;&nbsp;&nbsp;&nbsp; 2575388 |
|  |  | **6150370** |
| **Singapore 0.6%** | **Singapore 0.6%** | **Singapore 0.6%** |
| Jardine Cycle & Carriage Ltd.  | &nbsp;&nbsp;&nbsp; 104500 | &nbsp;&nbsp;&nbsp;&nbsp; 2316725 |
| Oversea-Chinese Banking Corp., Ltd.  | &nbsp;&nbsp;&nbsp; 117000 | &nbsp;&nbsp;&nbsp;&nbsp; 1156001 |
|  |  | **3472726** |
| **Spain 1.8%** | **Spain 1.8%** | **Spain 1.8%** |
| Banco Santander S.A.  | 1956502 | &nbsp;&nbsp;&nbsp;&nbsp; 6837856 |
| Repsol S.A.  | &nbsp;&nbsp;&nbsp; 169613 | &nbsp;&nbsp;&nbsp;&nbsp; 2786204 |
|  |  | **9624060** |
| **Sweden 1.6%** | **Sweden 1.6%** | **Sweden 1.6%** |
| Atlas Copco AB, A Shares  | &nbsp;&nbsp;&nbsp; 237205 | &nbsp;&nbsp;&nbsp;&nbsp; 2814689 |
| Nordea Bank Abp  | &nbsp;&nbsp;&nbsp; 302273 | &nbsp;&nbsp;&nbsp;&nbsp; 3533688 |

---

---

| | | |
|:---|:---|:---|
| SECURITY | NUMBER<br> OF SHARES<br>| VALUE ($) |
| SSAB AB, A Shares  | &nbsp;&nbsp;&nbsp;&nbsp; 85965 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 614446 |
| Swedish Orphan Biovitrum AB \* | &nbsp;&nbsp;&nbsp;&nbsp; 31518 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 702869 |
| Telefonaktiebolaget LM Ericsson, B Shares  | &nbsp;&nbsp;&nbsp; 126417 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 733277 |
|  |  | **8398969** |
| **Switzerland 10.4%** | **Switzerland 10.4%** | **Switzerland 10.4%** |
| ABB Ltd.  | &nbsp;&nbsp;&nbsp;&nbsp; 57000 | &nbsp;&nbsp;&nbsp;&nbsp; 1984492 |
| Cie Financiere Richemont S.A., Class A  | &nbsp;&nbsp;&nbsp;&nbsp; 66525 | &nbsp;&nbsp; 10255308 |
| Glencore plc  | &nbsp;&nbsp;&nbsp; 146052 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 978093 |
| Mobilezone Holding AG  | &nbsp;&nbsp;&nbsp;&nbsp; 37011 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 672047 |
| Nestle S.A.  | &nbsp;&nbsp;&nbsp; 116001 | &nbsp;&nbsp; 14153171 |
| Novartis AG  | &nbsp;&nbsp;&nbsp; 122819 | &nbsp;&nbsp; 11103947 |
| Roche Holding AG  | &nbsp;&nbsp;&nbsp;&nbsp; 43221 | &nbsp;&nbsp; 13492316 |
| UBS Group AG  | &nbsp;&nbsp;&nbsp; 180781 | &nbsp;&nbsp;&nbsp;&nbsp; 3858838 |
|  |  | **56498212** |
| **Taiwan 0.6%** | **Taiwan 0.6%** | **Taiwan 0.6%** |
| &nbsp;&nbsp;&nbsp;&nbsp; Taiwan Semiconductor Manufacturing Co., <br> Ltd. <br>| &nbsp;&nbsp;&nbsp; 176000 | **3105834** |
| **United Kingdom 13.7%** | **United Kingdom 13.7%** | **United Kingdom 13.7%** |
| Anglo American plc  | &nbsp;&nbsp;&nbsp;&nbsp; 76115 | &nbsp;&nbsp;&nbsp;&nbsp; 3282869 |
| AstraZeneca plc  | &nbsp;&nbsp;&nbsp;&nbsp; 64895 | &nbsp;&nbsp;&nbsp;&nbsp; 8502053 |
| BAE Systems plc  | &nbsp;&nbsp;&nbsp; 325841 | &nbsp;&nbsp;&nbsp;&nbsp; 3449366 |
| Barclays plc  | &nbsp;&nbsp;&nbsp; 845257 | &nbsp;&nbsp;&nbsp;&nbsp; 1943069 |
| Centrica plc  | 2940557 | &nbsp;&nbsp;&nbsp;&nbsp; 3663351 |
| Diageo plc  | &nbsp;&nbsp;&nbsp;&nbsp; 21148 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 924719 |
| GSK plc  | &nbsp;&nbsp;&nbsp; 428331 | &nbsp;&nbsp;&nbsp;&nbsp; 7523640 |
| Howden Joinery Group plc  | &nbsp;&nbsp;&nbsp; 292851 | &nbsp;&nbsp;&nbsp;&nbsp; 2498833 |
| HSBC Holdings plc  | 1381205 | &nbsp;&nbsp; 10177196 |
| Imperial Brands plc  | &nbsp;&nbsp;&nbsp; 267305 | &nbsp;&nbsp;&nbsp;&nbsp; 6705673 |
| Investec plc  | &nbsp;&nbsp;&nbsp; 921614 | &nbsp;&nbsp;&nbsp;&nbsp; 5881030 |
| Land Securities Group plc  | &nbsp;&nbsp;&nbsp;&nbsp; 48053 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 420983 |
| Legal & General Group plc  | &nbsp;&nbsp;&nbsp; 996297 | &nbsp;&nbsp;&nbsp;&nbsp; 3135285 |
| Man Group plc  | 1472933 | &nbsp;&nbsp;&nbsp;&nbsp; 4531411 |
| NatWest Group plc  | &nbsp;&nbsp;&nbsp; 239209 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 912596 |
| Plus500 Ltd.  | &nbsp;&nbsp;&nbsp; 135872 | &nbsp;&nbsp;&nbsp;&nbsp; 3114006 |
| Rio Tinto plc  | &nbsp;&nbsp;&nbsp;&nbsp; 13778 | &nbsp;&nbsp;&nbsp;&nbsp; 1078834 |
| Shell plc  | &nbsp;&nbsp;&nbsp; 138996 | &nbsp;&nbsp;&nbsp;&nbsp; 4080611 |
| Unilever plc  | &nbsp;&nbsp;&nbsp;&nbsp; 49748 | &nbsp;&nbsp;&nbsp;&nbsp; 2532126 |
|  |  | **74357651** |
| **Total Common Stocks**<br> **(Cost $467,487,901)** | **Total Common Stocks**<br> **(Cost $467,487,901)** | **546532074** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **SHORT-TERM INVESTMENTS** 4.8% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 4.8% OF NET ASSETS | **SHORT-TERM INVESTMENTS** 4.8% OF NET ASSETS |
| **Money Market Funds 4.8%** | **Money Market Funds 4.8%** | **Money Market Funds 4.8%** |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional U.S. Government <br> Money Market Fund, Premier Class <br> 4.18% *(b)*<br>| 23978352 | &nbsp;&nbsp; 23978352 |
| &nbsp;&nbsp;&nbsp;&nbsp; State Street Institutional U.S. Government <br> Money Market Fund, Premier Class <br> 4.18% *(b)(c)*<br>| &nbsp;&nbsp; 2365950 | &nbsp;&nbsp;&nbsp;&nbsp; 2365950 |
|  |  | **26344302** |
| **Total Short-Term Investments**<br> **(Cost $26,344,302)** | **Total Short-Term Investments**<br> **(Cost $26,344,302)** | **26344302** |
| **Total Investments in Securities**<br> **(Cost $493,832,203)** | **Total Investments in Securities**<br> **(Cost $493,832,203)** | **572876376** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**15**

------

Schwab International Core Equity Fund

**Portfolio Holdings** (Unaudited) continued

------

\* Non-income producing security.

*(a)* All or a portion of this security is on loan. Securities on loan were valued at $2,260,237. 

*(b)* The rate shown is the annualized 7-day yield.

*(c)* Security purchased with cash collateral received for securities on loan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

REIT — Real Estate Investment Trust

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

The following is a summary of the inputs used to value the fund's investments as of January 31, 2023:

---

| | | | | |
|:---|:---|:---|:---|:---|
| DESCRIPTION | QUOTED PRICES IN<br> ACTIVE MARKETS FOR<br> IDENTICAL ASSETS<br> (LEVEL 1)<br>| &nbsp;&nbsp; OTHER SIGNIFICANT<br> OBSERVABLE INPUTS<br> (LEVEL 2)<br>| &nbsp;&nbsp; SIGNIFICANT<br> UNOBSERVABLE INPUTS<br> (LEVEL 3)<br>| TOTAL |
| **Assets** |  |  |  |  |
| Common Stocks<sup>1</sup> <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $— | $354750397 | $— | $354750397 |
| &nbsp;&nbsp;&nbsp;&nbsp; Canada | &nbsp;&nbsp; 10355879 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 10355879 |
| &nbsp;&nbsp;&nbsp;&nbsp; Japan | &nbsp;&nbsp;&nbsp;&nbsp; 1350778 | &nbsp;&nbsp; 105717369 | &nbsp;&nbsp; — | &nbsp;&nbsp; 107068147 |
| &nbsp;&nbsp;&nbsp;&nbsp; United Kingdom | &nbsp;&nbsp;&nbsp;&nbsp; 8995036 | &nbsp;&nbsp;&nbsp;&nbsp; 65362615 | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 74357651 |
| Short-Term Investments<sup>1</sup> <br>| &nbsp;&nbsp; 26344302 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp; 26344302 |
| **Total** | **$47045995** | **$525830381** | **$—** | **$572876376** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>1</sup> As categorized in the Portfolio Holdings.

Fund investments in mutual funds are classified as Level 1, without consideration to the classification level of the underlying securities held by the mutual funds, which could be Level 1, Level 2 or Level 3.

**16** 

------

Schwab Active Equity Funds

**Notes to Portfolio Holdings (Unaudited)** 

------

Pursuant to Rule 2a-5 under the 1940 Act, the Board of Trustees (the Board) has designated authority to a Valuation Designee, the funds' investment adviser, to make fair valuation determinations under adopted procedures, subject to Board oversight. The investment adviser has formed a Pricing Committee to administer the pricing and valuation of portfolio securities and other assets and liabilities and to ensure that prices used for internal purposes or provided by third parties reasonably reflect fair value. The Valuation Designee may utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

Securities held in the funds' portfolio are valued every business day. The following valuation policies and procedures are used by the Valuation Designee to value various types of securities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Securities traded on an exchange or over-the-counter:** Traded securities are valued at the closing value for the day, or, on days when no closing value has been reported, at the mean of the most recent bid and ask quotes. Securities that are primarily traded on foreign exchanges are valued at the official closing price or the last sales price on the exchange where the securities are principally traded with these values then translated into U.S. dollars at the current exchange rate, unless these securities are fair valued as discussed below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Foreign equity security fair valuation:** The Valuation Designee has adopted procedures to fair value foreign equity securities that are traded in markets that close prior to the valuation of a fund's holdings. By fair valuing securities whose prices may have been affected by events occurring after the close of trading, the Valuation Designee seeks to establish prices that investors might expect to realize upon the current sales of these securities. This methodology is designed to deter "arbitrage" market timers, who seek to exploit delays between the change in the value of a fund's portfolio holdings and the net asset value (NAV) of a fund's shares and seeks to help ensure that the prices at which a fund's shares are purchased and redeemed are fair and do not result in dilution of shareholder interest or other harm to shareholders. When fair value pricing is used at the open or close of a reporting period, it may cause a temporary divergence between the return of a fund and that of its comparative index or benchmark.

• **Futures contracts:** Futures contracts are valued at their settlement prices as of the close of their exchanges.

• **Mutual funds:** Mutual funds are valued at their respective NAVs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Securities for which no quoted value is available:** The Valuation Designee has adopted procedures to fair value a fund's securities when market prices are not "readily available" or are unreliable. For example, a security may be fair valued when it's de-listed or its trading is halted or suspended; when a security's primary pricing source is unable or unwilling to provide a price; or when a security's primary trading market is closed during regular market hours. Fair value determinations are made in good faith in accordance with adopted valuation procedures. The Valuation Designee considers a number of factors, including unobservable market inputs, when arriving at fair value. The Valuation Designee may employ methods such as the review of related or comparable assets or liabilities, related market activities, recent transactions, market multiples, book values, transactional back-testing, disposition analysis and other relevant information. Due to the subjective and variable nature of fair value pricing, there can be no assurance that a fund could obtain the fair value assigned to the security upon the sale of such security.

In accordance with the authoritative guidance on fair value measurements and disclosures under generally accepted accounting principles in the United States of America (GAAP), the funds disclose the fair value of their investments in a hierarchy that prioritizes the significant inputs to valuation methods used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). If inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the valuation. If it is determined that either the volume and/or level of activity for an asset or liability has significantly decreased (from normal conditions for that asset or liability) or price quotations or observable inputs are not associated with orderly transactions, increased analysis and the Valuation Designee's judgment will be required to estimate fair value.

The three levels of the fair value hierarchy are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 — quoted prices in active markets for identical investments — Investments whose values are based on quoted market prices in active markets, and whose values are therefore classified as Level 1 prices, include active listed equities, mutual funds and futures contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 — other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) — Investments that trade in markets that are not considered to be active, but whose values are based on quoted market prices, dealer quotations or valuations provided by alternative pricing sources supported by observable inputs are classified as Level 2 prices. These generally include U.S. government and sovereign obligations, most government agency securities, investment-grade corporate bonds, certain mortgage products, less liquid listed equities, and state, municipal and provincial obligations. In addition, international securities whose markets close hours before the valuation of a fund's holdings may require fair valuations due to significant movement in the U.S. markets occurring after the daily close of foreign markets. The Valuation Designee has approved a vendor that calculates fair valuations of international equity securities based on a number of factors that appear to correlate to the movements in the U.S. markets.

**17**

------

Schwab Active Equity Funds

**Notes to Portfolio Holdings (Unaudited) (continued)**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 — significant unobservable inputs (including the Valuation Designee's assumptions in determining the fair value of investments) — Investments whose values are classified as Level 3 prices have significant unobservable inputs, as they may trade infrequently or not at all. When observable prices are not readily available for these securities, one or more valuation methods are used for which sufficient and reliable data is available. The inputs used in estimating the value of Level 3 prices may include the original transaction price, quoted prices for similar securities or assets in active markets, completed or pending third-party transactions in the underlying investment or comparable issuers, and changes in financial ratios or cash flows. Level 3 prices may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated in the absence of market information. Assumptions used due to the lack of observable inputs may significantly impact the resulting fair value and therefore the funds' results of operations.

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

REG87636JAN23

**18** 

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** SCHWAB CAPITAL TRUST

- **b. Investment Company Act file number:** 811-07704

- **c. CIK number of Registrant:** 0000904333

- **d. LEI of Registrant:** 549300PEK1H7N1HLC797

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 211 MAIN STREET

  - **City:** SAN FRANCISCO

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-648-5300

**Item A.2. Information about the Series.**

- **a. Name of Series:** Schwab Health Care Fund

- **b. EDGAR series identifier (if any):** S000005519

- **c. LEI of Series:** 5493000OCKQ3NPNPGA79

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-10-31

- **b. Date as of which information is reported:** 2023-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $851740589.78

**Total Liabilities:** $968687.02

**Net Assets:** $850771902.76

**Cash Not Reported:** $5182160.38

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000015021 | 6.56%                | -2.23%               | -0.57%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $4083681.82              | $49572340.57                               |
| Month 2  | $5551887.64              | $-25484039.58                              |
| Month 3  | $5997927.90              | $-4528128.24                               |

### Schedule of Portfolio Investments

| Name                                               | Title                                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Celltrion Inc                                      | Celltrion Inc                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |      6558 | NS      | $865532.74    | 0.10%             |  |  |  | No            |                  2 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd                       | Chugai Pharmaceutical Co Ltd                       | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |     25000 | NS      | $648127.02    | 0.08%             |  |  |  | No            |                  2 | On Loan: No      |
| AMN Healthcare Services Inc                        | AMN Healthcare Services Inc                        | CUSIP: 001744101<br>LEI: 529900W3ARRTCNFH2I39 | Long             | EC               | CORP              | US        |     24790 | NS      | $2375873.60   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                         | Vertex Pharmaceuticals Inc                         | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     74411 | NS      | $24042194.10  | 2.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                                  | Johnson & Johnson                                  | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    248067 | NS      | $40539109.14  | 4.76%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                             | UnitedHealth Group Inc                             | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     93193 | NS      | $46521013.67  | 5.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Intercept Pharmaceuticals Inc                      | Intercept Pharmaceuticals Inc                      | CUSIP: 45845P108<br>LEI: 254900JMB8TX5P688V24 | Long             | EC               | CORP              | US        |    109500 | NS      | $1999470.00   | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Cochlear Ltd                                       | Cochlear Ltd                                       | CUSIP: 000000000<br>LEI: 5493001OLLWY8KV5UC08 | Long             | EC               | CORP              | AU        |      6544 | NS      | $988645.43    | 0.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Prestige Consumer Healthcare Inc                   | Prestige Consumer Healthcare Inc                   | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    105946 | NS      | $6967008.96   | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| PerkinElmer Inc                                    | PerkinElmer Inc                                    | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     17181 | NS      | $2362902.93   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| QIAGEN NV                                          | QIAGEN NV                                          | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |     48506 | NS      | $2376794.00   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals Inc                       | Catalyst Pharmaceuticals Inc                       | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |    364830 | NS      | $5651216.70   | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                         | AbbVie Inc                                         | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    105553 | NS      | $15595455.75  | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonova Holding AG                                  | Sonova Holding AG                                  | CUSIP: 000000000<br>LEI: 5299004A0QNX7FBNHS61 | Long             | EC               | CORP              | CH        |     32377 | NS      | $8096569.65   | 0.95%             |  |  |  | No            |                  2 | On Loan: No      |
| Nihon Kohden Corp                                  | Nihon Kohden Corp                                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     65700 | NS      | $1726003.93   | 0.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Thermo Fisher Scientific Inc                       | Thermo Fisher Scientific Inc                       | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     32921 | NS      | $18775833.93  | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                           | Agilent Technologies Inc                           | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    126206 | NS      | $19193408.48  | 2.26%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                        | BioMarin Pharmaceutical Inc                        | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     52298 | NS      | $6032574.30   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| NextGen Healthcare Inc                             | NextGen Healthcare Inc                             | CUSIP: 65343C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30400 | NS      | $578208.00    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Axonics Inc                                        | Axonics Inc                                        | CUSIP: 05465P101<br>LEI: 549300LJY4X7N57VJL05 | Long             | EC               | CORP              | US        |     22200 | NS      | $1363080.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                                   | Novo Nordisk A/S                                   | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    185711 | NS      | $25700501.97  | 3.02%             |  |  |  | No            |                  2 | On Loan: No      |
| Jeol Ltd                                           | Jeol Ltd                                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     45000 | NS      | $1321381.23   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| Medtronic PLC                                      | Medtronic PLC                                      | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    256083 | NS      | $21431586.27  | 2.52%             |  |  |  | No            |                  1 | On Loan: No      |
| NuVasive Inc                                       | NuVasive Inc                                       | CUSIP: 670704105<br>LEI: 549300C5ZB4NZ6TWM881 | Long             | EC               | CORP              | US        |     97199 | NS      | $4432274.40   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                                   | Roche Holding AG                                   | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     60988 | NS      | $19038646.61  | 2.24%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                                         | Zoetis Inc                                         | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    117345 | NS      | $19419424.05  | 2.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                          | Halozyme Therapeutics Inc                          | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |    180847 | NS      | $9362449.19   | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                         | Zimmer Biomet Holdings Inc                         | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |    115912 | NS      | $14760234.08  | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                                | Elevance Health Inc                                | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |     33332 | NS      | $16665666.68  | 1.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                         | Biogen Inc                                         | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     15869 | NS      | $4616292.10   | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| CSPC Pharmaceutical Group Ltd                      | CSPC Pharmaceutical Group Ltd                      | CUSIP: 000000000<br>LEI: 529900M3XQCW234H8O91 | Long             | EC               | CORP              | HK        |   4122000 | NS      | $4699915.32   | 0.55%             |  |  |  | No            |                  2 | On Loan: No      |
| United Therapeutics Corp                           | United Therapeutics Corp                           | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     26883 | NS      | $7074799.11   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| United Laboratories International Holdings Ltd/The | United Laboratories International Holdings Ltd/The | CUSIP: 000000000<br>LEI: 2549007JL3XIH77JXN70 | Long             | EC               | CORP              | KY        |    752000 | NS      | $497856.77    | 0.06%             |  |  |  | No            |                  2 | On Loan: No      |
| IQVIA Holdings Inc                                 | IQVIA Holdings Inc                                 | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     62892 | NS      | $14428053.72  | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                        | Moderna Inc                                        | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     72238 | NS      | $12718222.28  | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                                            | GSK PLC                                            | CUSIP: 000000000<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |    858563 | NS      | $15080671.92  | 1.77%             |  |  |  | No            |                  2 | On Loan: No      |
| Avanos Medical Inc                                 | Avanos Medical Inc                                 | CUSIP: 05350V106<br>LEI: 549300YCXWOM7NEWMQ58 | Long             | EC               | CORP              | US        |    118742 | NS      | $3638254.88   | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Corp                                         | Cigna Corp                                         | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |     72444 | NS      | $22940841.48  | 2.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Integra LifeSciences Holdings Corp                 | Integra LifeSciences Holdings Corp                 | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |     51235 | NS      | $2935765.50   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                                    | CVS Health Corp                                    | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    283439 | NS      | $25004988.58  | 2.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Astellas Pharma Inc                                | Astellas Pharma Inc                                | CUSIP: 000000000<br>LEI: 529900IB708DY2HBBB35 | Long             | EC               | CORP              | JP        |     14600 | NS      | $214913.90    | 0.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Dentium Co Ltd                                     | Dentium Co Ltd                                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |      6593 | NS      | $633638.78    | 0.07%             |  |  |  | No            |                  2 | On Loan: No      |
| AstraZeneca PLC                                    | AstraZeneca PLC                                    | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    147669 | NS      | $19346478.29  | 2.27%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc                             | Intuitive Surgical Inc                             | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     32459 | NS      | $7974851.71   | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                          | Amgen Inc                                          | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     86365 | NS      | $21798526.00  | 2.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Medpace Holdings Inc                               | Medpace Holdings Inc                               | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |     15000 | NS      | $3316050.00   | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Ono Pharmaceutical Co Ltd                          | Ono Pharmaceutical Co Ltd                          | CUSIP: 000000000<br>LEI: 529900G26L4NG4GFJZ86 | Long             | EC               | CORP              | JP        |    360100 | NS      | $7813696.01   | 0.92%             |  |  |  | No            |                  2 | On Loan: No      |
| Veracyte Inc                                       | Veracyte Inc                                       | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |     89093 | NS      | $2238907.09   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                                | Abbott Laboratories                                | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    276358 | NS      | $30551376.90  | 3.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                                     | Lonza Group AG                                     | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |      3096 | NS      | $1766086.39   | 0.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Ipsen SA                                           | Ipsen SA                                           | CUSIP: 000000000<br>LEI: 549300M6SGDPB4Z94P11 | Long             | EC               | CORP              | FR        |     57884 | NS      | $6079845.80   | 0.71%             |  |  |  | No            |                  2 | On Loan: No      |
| Pfizer Inc                                         | Pfizer Inc                                         | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    443951 | NS      | $19604876.16  | 2.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp                                          | Hoya Corp                                          | CUSIP: 000000000<br>LEI: 353800X4VR3BHEUCJB42 | Long             | EC               | CORP              | JP        |     96700 | NS      | $10634284.39  | 1.25%             |  |  |  | No            |                  2 | On Loan: No      |
| Bio-Techne Corp                                    | Bio-Techne Corp                                    | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     62396 | NS      | $4970465.36   | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                           | Jazz Pharmaceuticals PLC                           | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     19055 | NS      | $2985156.30   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Molina Healthcare Inc                              | Molina Healthcare Inc                              | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |      9009 | NS      | $2809276.47   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                          | Edwards Lifesciences Corp                          | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |     32066 | NS      | $2459462.20   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi                                             | Sanofi                                             | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    146424 | NS      | $14338485.95  | 1.69%             |  |  |  | No            |                  2 | On Loan: No      |
| Universal Vision Biotechnology Co Ltd              | Universal Vision Biotechnology Co Ltd              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | TW        |     27000 | NS      | $294569.15    | 0.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Vir Biotechnology Inc                              | Vir Biotechnology Inc                              | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    135645 | NS      | $4008309.75   | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                         | Humana Inc                                         | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     22927 | NS      | $11731745.90  | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings Inc                              | Lantheus Holdings Inc                              | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |     30993 | NS      | $1782097.50   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| TTY Biopharm Co Ltd                                | TTY Biopharm Co Ltd                                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | TW        |    150000 | NS      | $388630.62    | 0.05%             |  |  |  | No            |                  2 | On Loan: No      |
| Danaher Corp                                       | Danaher Corp                                       | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    110440 | NS      | $29198127.20  | 3.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                      | Regeneron Pharmaceuticals Inc                      | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     13850 | NS      | $10504809.50  | 1.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Hansoh Pharmaceutical Group Co Ltd                 | Hansoh Pharmaceutical Group Co Ltd                 | CUSIP: 000000000<br>LEI: 254900Q6MR00EBXTPF42 | Long             | EC               | CORP              | KY        |    344000 | NS      | $704068.45    | 0.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Inmode Ltd                                         | Inmode Ltd                                         | CUSIP: 000000000<br>LEI: 984500DD95A35E9BD358 | Long             | EC               | CORP              | IL        |     19900 | NS      | $697495.00    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                                        | Novartis AG                                        | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |     98886 | NS      | $8940187.89   | 1.05%             |  |  |  | No            |                  2 | On Loan: No      |
| Mettler-Toledo International Inc                   | Mettler-Toledo International Inc                   | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      8493 | NS      | $13019089.56  | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonic Healthcare Ltd                               | Sonic Healthcare Ltd                               | CUSIP: 000000000<br>LEI: 549300NQQ5L2NONWR862 | Long             | EC               | CORP              | AU        |     41427 | NS      | $927863.46    | 0.11%             |  |  |  | No            |                  2 | On Loan: No      |
| Ansell Ltd                                         | Ansell Ltd                                         | CUSIP: 000000000<br>LEI: 549300NEGJ5G23VCJM45 | Long             | EC               | CORP              | AU        |    210040 | NS      | $4197765.78   | 0.49%             |  |  |  | No            |                  2 | On Loan: No      |
| Phibro Animal Health Corp                          | Phibro Animal Health Corp                          | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |     28238 | NS      | $434865.20    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                     | Merck & Co Inc                                     | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    402781 | NS      | $43262707.21  | 5.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Coloplast A/S                                      | Coloplast A/S                                      | CUSIP: 000000000<br>LEI: 529900NN7SOJ5QG82X67 | Long             | EC               | CORP              | DK        |     20897 | NS      | $2522987.49   | 0.30%             |  |  |  | No            |                  2 | On Loan: No      |
| STERIS PLC                                         | STERIS PLC                                         | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     16488 | NS      | $3404936.88   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                        | Waters Corp                                        | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |     37131 | NS      | $12200503.98  | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                     | Eli Lilly & Co                                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     70103 | NS      | $24125947.45  | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Hologic Inc                                        | Hologic Inc                                        | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |    109039 | NS      | $8872503.43   | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                            | Bristol-Myers Squibb Co                            | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    433163 | NS      | $31469291.95  | 3.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                                | Gilead Sciences Inc                                | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    317665 | NS      | $26664800.10  | 3.13%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-02-24

**Name of Applicant:** SCHWAB CAPITAL TRUST

**Signature:** Dana Smith

**Name of Signer:** Dana Smith

**Title:** CFO